The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed...

73
Tuborg Boulevard 3, DK-2900 Hellerup Central Business Reg. No. 10 49 68 37 Annual Report 2019 (Financial year 1 January 31 December) The Pharmaconomists’ Pension Fund Approved at the General Meeting of the Pension Fund on 29.06.2020 Chairman of the Meeting: Tina Øster Larsen

Transcript of The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed...

Page 1: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

Tuborg Boulevard 3, DK-2900 Hellerup – Central Business Reg. No. 10 49 68 37

Annual Report 2019 (Financial year 1 January – 31 December)

The Pharmaconomists’

Pension Fund

Approved at the General Meeting of the Pension Fund on 29.06.2020

Chairman of the Meeting:

Tina Øster Larsen

Page 2: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

2 Annual Report 2019

The Pharmaconomists’ Pension Fund

Contents

Management Review 3

Management Statement 10

The independent auditor’s report 11

Income Statement and Total Income Statement 15

Balance Sheet 16

Equity and Capital Base 18

Notes 19

Page 3: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

3 Annual Report 2019

The Pharmaconomists’ Pension Fund

Management Review The Pharmaconomists’ Pension Fund carries out pension fund activities. The Pension Fund accepts phar-maconomists as members; they are entitled and obliged to membership of the Pension Fund through their

collective labour market agreement or contract of employment. In addition, the Board of Directors may accept members working in similar positions and with a corresponding educational background. The Pension Fund has organised its activities in the form of investment activities in affiliated companies. However, the results obtained by the Pension Fund Group as a whole decide a member’s pension entitle-ment. The key figures in this report are thus given at Group level, unless otherwise specified.

Result for the year The Group’s result for 2019 was a profit of DKK 94.6 mill. The Board proposes to carry forward the profit to next year. Members’ contributions are at the level of 2018, while pension payments have increased. Consequently,

the Pension Fund is not growing, since pension payments exceed members’ contributions.

The total return before the pension return tax on the Pension Fund’s assets was 13.3%. The result for the year is deemed to be satisfactory and the Pension Fund remains well-consolidated. The year under review

Economy In 2019, the world economy was marked by uncertainty regarding the trade war between the US and Chi-na and Europe, respectively. Consequently, expectations for global growth fell from 3.6% in 2018 to 3% in 2019. In spite of uncertainty about the trade war, developments of economic key ratios were both positive and

negative. There is no sign of an actual recession at the moment. This has resulted in positive returns on the stock markets. The global stock market generated a 22% return in 2019.

Increases in stock markets were supported by a more lenient monetary policy pursued in both the US and the EU in 2019; there are no signs that this policy will be discontinued any time soon. 2019 saw a decline in interest rates by 0.75% in the US and 0.4% in Europe.

Increasing share prices and declining interest rates resulted in a positive return on the investments made by the Pension Fund. Account interest rate The Pension Fund’s account interest rate was 4.7 before tax in 2019. The account interest rate has been set at 3.54% before tax for 2020.

Conversion interest rate, adjusted For the purpose of ensuring stable, predictable pensions, the conversion interest rate was reduced as from October 2019 from 4.5 % to 2.75 %. Members receiving an old-age pension or anticipatory pension have the option of retaining the previous conversion interest rate of 4.5 % or choosing the lower rate.

Private savings

Members are offered the possibility of placing private savings with the Pension Fund as a flexible supple-ment to the pension scheme from their employer. Private savings are payment-guaranteed and may be established in the form of a retirement savings account, an instalment pension, or a life-long retirement pension. In 2019, members have started paying into voluntary, private savings.

Page 4: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

4 Annual Report 2019

The Pharmaconomists’ Pension Fund

Investment portfolio Return The total return in 2019 was 13.3 %, corresponding to DKK 1,323.6 mill. before tax.

Most asset classes contributed a positive return in 2019. The highest return was achieved on listed shares. Social responsibility On the basis of the UN millennium goals and the Paris climate agreement, the Pension Fund focuses

strongly on combating climate change, disseminating green energy and promoting sustainability. Seven of the millennium goals are hallmarks for the Pension Fund’s investment strategy in relation to responsibility. The policy and guidelines for responsible investments are in line with the principles of the UN Global Com-

pact. In connection with the UN Global Compact, the Pension Fund has adopted an additional policy of not investing in controversial weapons or tobacco. Furthermore, the Pension Fund pursues a responsible tax policy and a policy of active ownership.

Active ownership is exercised primarily by entering into a dialogue with the companies in which invest-ments are made, so as to ensure that they comply with the policies and guidelines adopted by the Board of Directors. The purpose is to ensure the long-term value creation of these companies, which also generates the highest possible returns to the members of the Pension Fund. If a company does not live up to the Pension Fund’s policies and guidelines, PKA enters into a dialogue with the company concerned. If there are no prospects of the company improving in the longer term, and if the company continues to act against

the policies and guidelines, the company will be excluded from the Pension Fund’s investment universe. Excluded companies are registered on a negative list and published on the Pension Fund’s website; the website also contains information about companies on the observation list and companies with which a dialogue has commenced. The Pension Fund does not invest in companies whose total exposure towards coal production exceeds

25%, where such companies have no intention of changing their business model to bring it in line with the

objectives of the Paris Agreement. For clarification of the companies’ approach to the Paris Agreement, PKA enters into a dialogue with those companies that have a coal exposure above 25%. The purpose of this dialogue is to reduce the said companies’ activities in coal and ensure conversion to more climate-friendly energy sources. This process has resulted in the Pension Fund excluding 60 coal companies, while dialogues are ongoing with four companies.

There is also a focus on oil and gas companies and whether their business models are in accordance with the climate objective laid down in the Paris Agreement. Against this background, a total of 63 oil and gas companies have been excluded, while dialogues are ongoing with seven companies. 2019 saw special focus on the transport sector, where PKA has entered into a dialogue with 15 companies, which combined make up 3/4 of the Pension Fund’s total investments in the car sector. At the end of 2019, the dialogue with these companies ended and one company was excluded, while five were placed on the

observation list. PKA monitors these companies closely and they will be re-assessed at the end of 2020. Furthermore, PKA forms part of the global investor initiative Climate Action 100+, the purpose of which is

to enter into a dialogue with the biggest CO2-emitting companies in the world to insist that they present business plans in line with the objectives of the Paris Agreement. This initiative continues until 2022, and in 2019 the Board of Directors decided that when the initiative expires in 2022, the Pension Fund will ex-

clude the companies that do not live up to the requirement for a sustainable business plan. In cooperation with the other pension funds in PKA, the Pension Fund has an ambitious goal: 10% of as-sets, corresponding to a total of DKK 30 bn, is to be invested in climate projects at the end of 2020, against a total of DKK 26.5 bn at the end of 2019. In 2020, the continued focus will thus be on making green investments that provide good returns to members. In 2019, PKA and other Danish pension funds have announced that they will invest an additional DKK 350 bn in green assets before the end of 2030.

The Pension Fund is also facing growing requirements for the handling of climate-related, financial risks. Consequently, in 2020 the Pension Fund expects to publish its first report in line with the recommendations from the Task Force on Climate-Related Financial Disclosures to explain how climate risks are handled in investment work. One way of doing this is to integrate ESG factors in investments, so as to give higher priority in investment work to companies that behave well in terms of environment, workers’ rights and

Page 5: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

5 Annual Report 2019

The Pharmaconomists’ Pension Fund

human rights; at the same time, the Pension Fund does not compromise on return requirements. PKA finds that the companies which are behaving well on these parameters create better returns in the long run and a better world for our members. Cooperation on investments and cash flow The Pension Fund’s assets are managed by PKA A/S. The Pension Fund has concluded an agreement with

the other pension funds administered by PKA A/S on efficient and rational management of investments and cash flow, so as to achieve the highest possible return while minimising costs. Derivative financial instruments The Pension Fund makes use of derivate financial instruments for investment and hedging purposes.

Risks and solvency associated with the Pension Fund’s business model The Pension Fund’s business model is simple in a risk perspective. The model rests on a labour-market-agreement-based, collective, solidarity-based labour market pension scheme.

The most significant risks are market risks, insurance-related risks and outsourcing risks. Market risks

The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of -0.75% as at 1 January 2020, just as the Pension Fund still has some members with an interest rate of 4.50%. This involves interest risk exposure, which is hedged on an ongoing basis. The Pension Fund wishes to deliver robust pensions to its members. This is ensured through a long-term investment strategy, whose aim is to achieve high, stable returns in a responsible way; as a minimum, these investments must be able to meet the return requirement from the announced pensions. Long-

term low returns on investment assets or major financial losses constitute a risk when it comes to deliv-ering robust pensions. This exposure is the Pension Fund’s market risk. This risk is mitigated by spread-ing investments to cover a wide range of different asset classes. Investments are made collectively for members. Any losses on investments must be covered collectively and the share of bonus potentials in the Pension Fund ensures that any losses on the financial markets

are not charged to members’ deposits in individual years, but that instead members receive the account

interest announced at any given time on their deposits. Risk-taking is a precondition for achieving an adequate return that will guarantee robust pensions. In this connection, the Board of Directors has a major task in deciding on the Pension Fund’s risk appetite in the form of a chosen investment strategy.

The Pension Fund’s risk appetite is decided on the basis of two goals. The Pension Fund protects the members’ pensions in the Risk Management Model and the Pension Fund complies with applicable sol-vency rules (SCR). In its risk management policy, the Board of Directors lays down the safety levels for the thresholds of the Risk Model, thereby providing the risk framework for protecting pensions. In addi-tion, solvency excess cover may, in special circumstances, set the framework for the Pension Fund’s risk-taking.

The Pension Fund has a capital plan and an emergency plan based on the risk management model (PBG) and the solvency capital requirement (SCR). In the capital plan, the financial situation in the Pension Fund’s strategic planning period is deemed to be reassuring.

Insurance risks The Pension Fund provides life-long pensions, so in risk terms the Pension Fund is exposed to changes in

life expectancy among its members. The Pension Fund is a solidarity-based scheme with disablement cover without any required health infor-mation upon admission, as long as the member is in one of the occupational groups that are comprised. In risk terms, the Pension Fund is exposed to the development in the number of anticipatory pension recipients among its members.

The Pension Fund monitors developments in its insurance risks closely and makes provisions in accor-dance with the life expectancy benchmark laid down by the Danish FSA.

Page 6: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

6 Annual Report 2019

The Pharmaconomists’ Pension Fund

Outsourcing The Pension Fund uses outsourcing to a considerable extent. Direct outsourcing goes to PKA A/S, which in turn has outsourced many operations to Forca A/S.. The administration of property investments has been outsourced to DEAS A/S. From 2020, some property administration has been outsourced to Newsec. Furthermore, some administration of securities has been outsourced to Forca A/S and to Nykredit portfo-

lio administration, while the management of securities has been outsourced to a number of portfolio managers. Risk is managed in the form of controls and service delivery agreements. Capital

Equity increased in 2019 by DKK 94.6 mill. to DKK 1,340.3 mill. The capital base is now DKK 1,785.9mill. against DKK 1,652.3 mill. in 2018. The SCR solvency requirement has been calculated using the standard model. As at 1 January 2019, SCR

has been calculated to be DKK 492.9 mill., while at the end of 2019 it amounted to DKK 561.3 mill. The solvency cover key ratio as a percentage is only calculated for the Pension Fund, and no key ratios are

prepared for the group, since the group covers only one pension fund. The solvency cover as a percentage over the last five years is given in the table below.

2015 2016 2017 2018 2019

Solvency cover in % 514 326 321 335 318 The Financial Statements Order was change with effect from 2016. It has not been deemed practically possible to change the figures for the period before 2016 to streamline them with the new method. Consequently, the figures for 2015 are not directly comparable with 2016-2019.

The sensitivity analysis is given in the Pension Fund’s solvency and financial conditioning report (SFCR) 2019, which is available on the following website: www.pka.dk.

Bonus policy

The pension scheme is based on the parties to the agreement having decided to have a collective, soli-darity-based approach with uniform pension, where members are placed equally as far as possible:

No health information upon admission

Same return, regardless of admission date

Same price for insurance policies, regardless of age

Same price for administration.

When bonus rates are determined, this is done on this basis and with a wish to ensure a stable develop-ment over time of members’ pensions. Bonus rates are intended to support the investment strategy de-cided by the Board of Directors, as well as statutory requirements regarding fairness and minimum capi-tal.

This collective, solidarity-based approach means that any losses, regardless of their origin, may be cov-ered by the Pension Fund’s reserves on collective, solidarity-based principles. Bonus potentials may be used fully to cover members’ share of a loss. This appears from Article 1 (2) of the Pension Fund’s bonus regulations.

The Pension Fund equity is owned by the members, and the result accrues to members in its entirety.

Page 7: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

7 Annual Report 2019

The Pharmaconomists’ Pension Fund

Superannuation provisions Provisions for pension agreements increased in 2019 by DKK 692 mill. to DKK 9,238 mill. Provisions are affected primarily by the decline in the regulatory interest graph. Uncertainty of recognition and measurement

When the Annual Report is prepared, a number of estimates and assessments of future aspects are made; these have an influence on the accounting value of assets and commitments. The most significant areas concern pension obligations and the valuation of unlisted, alternative invest-ments and properties. These areas are the same as when the 2018 Annual Report was prepared.

Management finds that the assumptions made are responsible, but associated with uncertainty. The accounting estimates are described in more detail in note 1”Accounting Policies”.

Events after the Balance Sheet date On 30 January 2020, the government concluded an agreement on Section 5 (2) of the Housing Control Act. This agreement will introduce a number of initiatives which may influence the valuation of the Pension

Fund’s investments in older residential properties covered by the possibility of Section 5 (2) renovations. The agreement has not been finally adopted and the ultimate design is still associated with uncertainty. The effect of this intervention is deemed to have no significant impact on the Pension Fund’s valuation of this type of properties. At the end of February and in the beginning of Mach 2020, the financial markets reacted strongly when

Covid-19 spread to Europe; share prices have fallen markedly and long-term interest rates have also gone down. The Pension Fund is robust and well-prepared for such challengers because of a well-diversified portfolio. Other than that, no events after the Balance Sheet date have any significant influence on the financial standing of the Pension Fund or the Group.

Expectations regarding the future Uncertainty about growth will continue into 2020 and will characterize the financial markets. A number of factors are in play, including the outcome of the trade war between China and the US. The UK left the EU on 31 January 2020. By the end of 2020, a new trade agreement is to be negotiated. If these efforts are unsuccessful, a ”Hard Brexit” is still a possibility; this may have major economic conse-

quences, primarily for the UK, but also for the EU. Crises caused by climate impact continue, most recently with the disastrous fires in Australia. This has an increasing influence on the global economy. The effects are difficult to predict, but will often be significant. At the end of February and in the beginning of March 2020, the financial markets have reacted strongly when Covid-19 spread to Europe; share prices have fallen markedly and long-term interest rates have also

gone down. In previous epidemics, there have been no long-term effects on the financial markets. This is because the scope of those epidemics was restricted, before the epidemics could have a long-term effect on economic activity.

The Covid-19 outbreak is expected to have a significant influence on global, economic activities in the short and medium term, while the long-term implications are uncertain – since they depend on the scope

and duration of Covid-19. Administration The Pension Fund and the affiliated enterprises are administered by PKA A/S. Management and the four key functions under Solvency II are employed by the Pension Fund, but their salaries are not paid by the Pension Fund.

Page 8: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

8 Annual Report 2019

The Pharmaconomists’ Pension Fund

The Pension Fund Group The Pension Fund’s affiliated (wholly owned) companies as at 31 December 2019 can be seen from the Group chart.

The Pharmaconomists’ Pension Fund

The Pharmaconomists’ Property Company (plc)

FarmaPension A/S

The Pension Fund’s Property Company (plc) The purpose of the company is to own and operation real property, so as to obtain a long-term return on the invested capital. The company’s result for 2019 was a loss of DKK 0.2 mill., which is in accordance with expectations.

The Pharmaconomists’ Property Company plc participates in partnerships with other PKA-affiliated property companies. These partnerships do not publish independent annual reports, in accordance with the provi-sions of the Danish Financial Statements Act. The partnerships are integrated on a pro rata basis in the financial statements of the partners. FarmaPension A/S

The company has no activities. The company has submitted a request for repayment of wrongly collected VAT for a past period. The Danish tax authorities have not yet started processing the request. The result for 2019 is 0.0 mill.

Audit Committee In accordance with legislation, the Pension Fund must establish an Audit Committee. The chairman must be independent and at least one member must have qualifications in accounting or auditing.

The chairman of the Audit Committee is Susanne Kure, who meets the requirements both for independ-ence and for qualifications in accounting or auditing. The other member of the Audit Committee is Su-sanne Engstrøm. Progress report on compliance with the goal regarding the underrepresented gender at man-agement level

The Financial Services Act requires that financial companies must set a target for gender representation on the Board of Directors and prepare a policy on equal representation if one gender is underrepresented on the Board. Such underrepresentation exists if either gender has less than 40% of the Board members. The rules of setting a target for gender representation on the Board of Directors are based on the Board members elected by the general meeting; however, in the Pension Fund, the majority of Board members

are appointed by social partners concluding labour market agreements. That is why it will not be correct to adopt a target for the Board members elected by the General Meeting; consequently, the Board has adopted a target for the gender composition of the Board of Directors as a whole. The Board has decided that the target for men on the Board of Directors is to be at least 25 %, while the target for women on the Board is to be at least 40 %. At the end of the year under review, the split on the Board of Directors was 37.5% men and 62.5% women.

The goals laid down have thus been met. No policy has been adopted regarding equal representation in the management layers below the Executive Management of the Pension Fund. The Pension Fund is fully administered by PKA A/S. As at 31 December 2019, PKA A/S had 46% women and 54% men in the management layers below the Executive Manage-ment so the preparation of a policy in this field is not required.

Page 9: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

9 Annual Report 2019

The Pharmaconomists’ Pension Fund

Other board/management positions: The Executive Management holds the following other board/management positions: Managing Director Jon Steingrim Johnsen

Man. Dir. of Pensionskassernes Administration A/S Man. Dir. of PKA+ Pension Forsikringsselskab A/S Man. Dir. of four pension funds administered by PKA A/S Man. Dir. of State Registered Nurses’ and Medical Secretaries’ Property Company Man. Dir. of Healthcare Professionals’ Property Company Man. Dir. of Social Workers’, Social Pedagogues’ and Office Staff Property Company

Manager of PKA Ejendomme af 2012 I/S Chairman of the Board of A/S Kjøbenhavns Ejendomsselskab Chairman of the Board of Forstædernes Ejendomsaktieselskab Chairman of the Board of Institutional Holding P/S Chairman of the Board of PKA Private Funds III P/S Chairman of the Board of IIP Denmark GP ApS

Chairman of the Board of IIP Denmark P/S

Chairman of the Board of PKA Venture I GP ApS Chairman of the Board of Poppelstykket 12 A/S Chairman of the Board of Rugårdsvej Odense A/S Chairman of the Board of PKA Skejby Komplementar ApS Chairman of the Board of PKA Skejby P/S Chairman of the Board of Farmapension A/S Member of the Board of Forca A/S

Member of the Board of AIP Management P/S Member of the Board of Ringkjøbing Landbobank A/S The Board members hold the following other board/management positions: Chairman of the Board Henrik Klitmøller Rasmussen

Board member of MP Pension – Pensionskassen for Magistre og Psykologer Board member of MP Investment Management A/S

Board member Jørgen Moestrup Board member of A-Dosispak Komplementar ApS Board member of Danmarks Apotekerforenings Jubilæumsfond

Board member Jesper Gulev Larsen Chairman of the Board of Pharmakon A/S Board member of D.A. Invest og Udvikling A/S Board member Susanne Kure, Chairman of the Audit Committee Chairman of the Board of Changegroup Holding A/S and 1 of the company’s wholly owned subsidiaries Board member and Chairman of the Audit Committee of PKA+ Pension Forsikringsselskab A/S

Board member and member of the Audit Committe of the Social Workers’, Social Pedagogues’ and Offfice Staff Pension Fund Board member of Investeringsselskabet af 24. februar 2015 A/S Board member of Genan Holding A/S

Board member Susanne Engstrøm, member of the Audit Committee

Other Board members have no additional board/management positions.

Page 10: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

10 Annual Report 2019

The Pharmaconomists’ Pension Fund

Management Statement We have today presented the Annual Report for The Pharmaconomists’ Pension Fund for the 1 January – 31 December 2019 financial year.

The Annual Report is submitted in accordance with the Danish Financial Business Act. We find that the consolidated accounts and financial statements give a true and fair view of the Group’s and the Pension Fund’s assets, liabilities and financial position as at 31 December 2019, as well as the result of the Group’s and the Pension Fund’s activities in the 1 January – 31 December 2019 financial

year. We consider that the Management Review gives a true and fair view of developments in the Group’s and the Pension Fund’s activities and financial standing, the result for the year and the Group’s and Pension Fund’s financial position, as well as describing significant risks and uncertainty factors faced by the Group and the Pension Fund.

We recommend that the Annual Report be adopted by the General Meeting. Hellerup, 23 March 2020 Executive Management:

Jon Steingrim Johnsen Managing Director

Hellerup, 23 March 2020 Board of Directors:

Henrik Klitmøller Rasmussen

Chairman

Ann-Mari Damholt Grønbæk

Lise Wieweg Rosendahl Hermansen Susanne Engstrøm

Jesper Gulev Larsen Susanne Kure

Jørgen Moestrup

Page 11: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

11 Annual Report 2019

The Pharmaconomists’ Pension Fund

The independent auditor’s report To the members of the Pharmaconomists’ Pension Fund

Opinion

In our opinion, the Consolidated Accounts and Financial Statements give a fair view of the Group’s and the Pension Fund’s assets, liabilities and financial position as at 31 December 2019, as well as of the result of the Group’s and Pension Fund’s activities in the 1 January – 31 December 2019 financial year in accor-dance with the Danish Financial Business Act. Our opinion is in line with our long-form audit report to the Audit Committee and the Board of Directors.

What have we audited The Consolidated Accounts and Financial Statements of the Pharmaconomists’ Pension Fund for the finan-cial year from 1 January – 31 December 2019, comprising the Income Statement and Total Income State-

ment, the Balance Sheet, the Equity Statement and Notes, including Accounting Policies (’the Financial Statements’).

Basis for our opinion We have carried out our audit in accordance with international audit standards (ISA) and the additional requirements in force in Denmark. Our responsibility according to these standards and requirements is described in more detail in the section of this auditor’s report entitled The auditor’s responsibility for the audit of the financial statements. We find that the audit proof we have secured is adequate and suitable as a basis for our opinion.

Independence We are independent of the Group in accordance with international ethical rules for auditors (IESBA’s Ethical Rules) and the additional requirements in force in Denmark, just as we are in compliance with our other ethical commitments i accordance with IESBA’s Ethical Rules. In our best conviction, no prohibited non-audit services, as specified in Article 5 (1) of Regulation (EU) No.

537/2014, have been performed. Appointment We were first appointed as the auditor for the Pharmaconomists’ Pension Fund at the General Meeting on 27 April 2018 for the 2017 financial year. We were appointed through a decision by the General Meeting for a total consecutive assignment period of two years up to and including the 2019 Financial Statements.

Central aspects of the audit Central aspects of the audit are the aspects which, in our professional assessment, were the most signifi-cant ones in our audit of the 2019 Financial Statements. We dealt with these aspects as part of our audit of the Financial Statements as a whole and the wording of our opinion on the said audit. We offer no separate opinion on these aspects.

Central aspects of the audit How we have processed the central aspects in the audit

Measuring of unlisted investments

Unlisted investments consist of investments made indirectly through funds as well as direct owner-ship. Investments have been made primarily in infrastructure, including wind turbines and other types of energy, business properties and dwelling properties, private equity and disaster insurance. To a smaller extent, investments have been made

in forests & agriculture, as well as direct loans to business enterprises. Investments form part of the account item entitled Investment properties, Investments in affiliated and associated companies, and Other financial in-vestment activities.

Measuring of unlisted investments

We reviewed and assessed procedures and internal controls for measuring unlisted investments. We assessed and tested the valuation models used by Management. We tested by sampling the connection between the

assumptions used and the calculation of current values. In addition, we tested prices reported by external managers, just as we carried out internal follow-up on prices and market development. We challenged Management estimates used for calculating current values; we did this based on our

knowledge of the portfolio and the market devel-

Page 12: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

12 Annual Report 2019

The Pharmaconomists’ Pension Fund

Directly owned, unlisted investments are measured at an estimated current value, primarily based on valuation models and assumptions, including Man-agement estimates, which are not observable for

third parties. Unlisted investments owned indirectly through funds and associations and administered externally and measured at an estimated current value based on reports from investment managers, supplemen-tary information about price developments, and

analyses of valuations. We focused on measuring unlisted investments, because the calculation is complex and involves considerable Management estimates.

Reference is made to the mention in Consolidated

Accounts and Financial Statements of ’Accounting estimates’ in note 1, ’Investment properties’ in note 8, ‘Break-down based on valuation of investment assets and financial commitments’ in note 10, and ’Shares in associated companies’ in note 16.

opment.

Measuring of superannuation provisions The Pension Fund has made provisions for pension agreements and investment contracts totalling DKK 9,238 mill., which is 73.7% of the total Balance

Sheet.

Provisions consist primarily of pension provisions towards guaranteed payments, individual bonus potential, collective bonus potential, and risk mar-gin.

The calculation is based on actuary principles and involves significant accounting estimates linked to the actuary assumptions regarding the timing and scope of future payments to policyholders. The actuary assumptions cover, most significantly,

the interest graph for discounting, life expectancies, mortality, disablement, buy-back probability and costs. We focused on measuring superannuation provi-sions, because the calculation of these provisions is

complex and involves considerable accounting es-

timates. Reference is made to the mention in the Consoli-dated Accounts and Financial Statements regarding ’Accounting estimates’ in note 1, as well as ’Pension provisions’ in note 14.

We reviewed and assessed the Pension Fund’s pro-cedures and internal controls established in order to ensure that provisions for pension agreements and

investment contracts are measured correctly.

In connection with the audit, we used our own ac-tuaries to assess the actuary models and assump-tions used by the Pension Fund, as well as the cal-culations made, including future payment flows.

We assessed and challenged the most significant actuary assumptions, such as the interest graph for discounting, life expectancies, mortality, disable-ment, buy-back probability and costs based on our experience and knowledge of the industry, so as to be able to assess whether these assumptions are in

accordance with market practices as well as regula-tory and accounting-related requirements. This work included an assessment of the continuity of the basis for calculating provisions.

Page 13: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

13 Annual Report 2019

The Pharmaconomists’ Pension Fund

Statement regarding the Management Review Management is responsible for the Management Review.

Our opinion about the Financial Statements does not cover the Management Review and we express no opinion with any certainty on the Management Review.

When we carry out our audit of the Financial Statements, it is our responsibility to read the Management Review and, in this connection, to consider whether the Management Review is significantly inconsistent with the Financial Statements or seems to contain material misstatements given the knowledge we have

obtained in our audit or in any other way.

Furthermore, our responsibility includes considering whether the Management Review contains the re-quired information as specified in the Danish Financial Business Act.

Based on our work, we find that the Management Review is in accordance with the Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Business Act. We have found no material misstatements in the Management Review.

Management’s responsibility for the Financial Statements

Management is responsible for preparing and presenting Consolidated Accounts and Financial Statements that give a true and fair view in accordance with the Danish Financial Business Act. Furthermore, Man-agement is responsible for the internal controls which Management deems to be necessary for the prepa-ration of Financial Statements without material misstatements regardless of whether such misstatements are the result of fraud or error.

When preparing the Financial Statements, Management is responsible for assessing the ability of the Group and the Pension Fund to continue operations, for giving information about matters regarding con-

tinued operation, where this is relevant, and for preparing the Financial Statements on the basis of the accounting principles for a going concern, unless Management either intends to liquidate the Group or the Pension Fund or discontinue operations, or has no other realistic alternative than to do so.

The auditor’s responsibility for the audit of the Consolidated Accounts and Financial Statements Our aim is to achieve a high degree of certainty that the Financial Statements as a whole are free of mate-rial misstatements, regardless of whether such misstatements are the result of fraud or error, and to pre-

pare an audit report with our opinion. A high degree of certainty means a high level of certainty, but in-volves no guarantee that an audit carried out in accordance with international auditing standards and the additional requirements in Denmark will always discover material misstatements if such exist. Misstate-ments may arise as a result of fraud or error and may be considered significant if it is reasonably to be expected that, individually or jointly, they will have an influence on financial decisions made by users of the accounts on the basis of the Financial Statements.

As part of an audit carried out in accordance with international audit standards and the additional require-ments in Denmark, we make professional assessments and maintain a professional scepticism during our

audit. In addition:

We identify and assess the risk of material misstatements in the Financial Statements, regardless of whether such misstatements are the result of fraud or error, and we plan and carry out audit action as a reaction to these risks and achieve audit proof which is adequate and suitable to form the basis of our opinion. The risk of not discovering material misstatements caused by fraud is higher than if mate-rial misstatements are the result of error, since fraud may come from conspiracy, forgery, deliberate

omissions, misguidance or disregard for internal controls.

We obtain an understanding of the internal controls that are relevant to the audit, so as to be able to carry out audit action, which is suitable in the circumstances, but not in order to be able to offer an opinion about the efficiency or effectiveness of the Group’s and the company’s internal controls.

We decide whether the accounting policies applied by Management are suitable, and whether the ac-counting estimates and associated information prepared by Management are reasonable.

We conclude whether Management’s preparation of the Financial Statements on the basis of a going concern accounting principle is suitable and whether, on the basis the audit proof obtained, there is

any significant uncertainty associated with events or matters which may create substantial doubts about the Group’s and the Pension Fund’s ability to continue operations. If we find that significant un-certainty exists, our audit report must give information about this in the Financial Statements or, if such information is not adequate, we must modify our opinion. Our opinions are based on the audit proof obtained up to the date of our audit report. However, future events or matter may mean that the Group and Pension Fund will no longer be able to continue operations.

Page 14: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

14 Annual Report 2019

The Pharmaconomists’ Pension Fund

We assess the overall presentation, structure and contents of the Consolidated Accounts and Financial Statements, including the Notes, and whether the Consolidated Accounts and Financial Statements re-flect the underlying transactions and events in such a way that a fair view is given thereof.

We obtain adequate, suitable audit proof in regard to the financial information in the companies or the business activities of the Group, so as to be able to give an opinion about the Consolidated Accounts. We are responsible for managing, supervising and performing the Group audit. We have sole responsi-

bility for our audit opinion.

We communicate with the Executive Management, for example about the planned scope and timing of the audit, as well as about significant observations during our audit, including any significant deficiencies in regard to internal controls which we may identify during our audit.

We also make a statement to the Executive Management specifying that we have complied with relevant ethical requirements concerning independence and we inform the Executive Management about all rela-tions and other matters which may reasonably be thought to influence our independence and, where rele-vant, we inform about any precautions taken.

Based on the matters communicated to the Executive Management, we decide which matters were the most significant ones in the audit of the Financial Statements for the period concerned and were thus the central aspects in our audit. We describe these aspects in our audit report, unless legislation or other regu-lations excludes such publication, or if in extreme cases we may decide that aspects are not to be commu-nicated in our audit report, because the negative consequences thereof could reasonably be expected to

outweigh the advantages the public interest in such communication.

Copenhagen, 23 March 2020 PricewaterhouseCoopers

State-authorized Audit Partnership Central Business Reg. No. 33 77 12 31

Christian Fredensborg Jakobsen Per Rolf Larssen

State-authorized Public Accountant State-authorized Public Accountant

mne16539 mne24822

Page 15: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

15 Annual Report 2019

The Pharmaconomists’ Pension Fund

Income Statement and Total Income Statement

All amounts in DKK mill. Pension Fund Consolidated

Note 2019 2018 2019 2018

Gross member contributions 3 202.4 199.5 202.4 199.5

Total member contributions, own account 202.4 199.5 202.4 199.5

Income from affiliated companies 0.5 2.4

Income from associated companies 37.3 37.5 37.3 37.5

Income from investment properties 0.1 0.1 0.5 2.5

Interest income and dividend, etc. 624.0 -137.0 624.0 -137.0

Price adjustments 4 674.7 -146.5 674.7 -146.5

Interest costs -0.8 -1.4 -0.8 -1.4

Administration costs in connection with

investment activities -12.2 -9.9 -12.2 -9.9

Total return on investment 1,323.6 -254.7 1,323.6 -254.7

Pension return tax -200.5 41.9 -200.5 41.9

Pension payments -497.1 -463.3 -497.1 -463.3

Total pension payments, own account -497.1 -463.3 -497.1 -463.3

Change to pension provisions, own

acc. 5 -691.7 408.9 -691.7 408.9 Change to profit margin 0.0 0.0 0.0 0.0

Change to surplus capital -39.0 15.9 -39.0 15.9

Administration costs -3.2 -3.3 -3.2 -3.3

Pension-related operating costs, own

acc. 6 -3.2 -3.3 -3.2 -3.3

Transferred return on investment -101.2 66.1 -101.2 66.1

TECHNICAL PENSION RESULT -6.6 11.0 -6.6 11.0

Investment return on equity 116.0 -80.3 116.0 -80.3

PROFIT BEFORE TAX 109.4 -69.2 109.4 -69.2

Pension return tax, equity -14.8 14.2 -14.8 14.2

PROFIT FOR THE YEAR 94.6 -55.1 94.6 -55.1

OTHER TOTAL INCOME 0.0 0.0 0.0 0.0

TOTAL INCOME FOR THE YEAR 94.6 -55.1 94.6 -55.1

Realised profit 7

Profit for the year is transferred to equity.

Page 16: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

16 Annual Report 2019

The Pharmaconomists’ Pension Fund

Balance Sheet

ASSETS

All amounts in DKK mill. Pension Fund Consolidated

Note 2019 2018 2019 2018

Investment properties 8 3.6 3.6 8.1 3.6

Capital investment in affiliated companies 16 11.0 43.4

Capital investment in associated companies16 284.1 250.8 284.1 250.8

Total investment in affiliated and

associated companies 295.1 294.1 284.1 250.8

Capital investment 234.7 83.1 234.7 83.1

Mutual trust investment 5,456.9 4,656.6 5,456.9 4,656.6

Bonds 5,795.7 5,253.5 5,795.7 5,253.5

Other loans 257.8 270.8 257.8 270.8

Deposits with credit institutes 243.1 93.2 244.7 137.1

Derivative financial instruments 9 85.7 89.7 85.7 89.7

Total other financial investment

assets 12,074.0 10,446.9 12,075.5 10,490.9

TOTAL INVESTMENT ASSETS 10 12,372.7 10,744.6 12,367.8 10,745.3

Receivables related to direct pension business with pension savers 0.0 0.0 0.0 0.0

Receivables from affiliated companies 0.0 0.1

Other receivables 0.0 0.0 0.1 0.1

TOTAL RECEIVABLES 0.0 0.1 0.1 0.1 Deferred tax assets 76.3 207.0 76.3 207.0

Cash in hand and at bank 0.1 0.1 0.1 0.1

OTHER ASSETS, TOTAL 76.4 207.1 76.4 207.1

Interest receivable 27.4 29.5 27.4 29.5

Other prepayments and accruals 56.2 55.3 56.2 55.3

TOTAL PREPAYMENTS AND ACCRUALS 83.6 84.8 83.6 84.8

TOTAL ASSETS 12,532.7 11,036.6 12,527.9 11,037.3

Break-down based on valuation of

investment assets and financial

commitments 10

Guarantees 11 Contingent asset 12

Page 17: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

17 Annual Report 2019

The Pharmaconomists’ Pension Fund

Balance Sheet

LIABILITIES

All amounts in DKK mill. Pension Fund Consolidated

Note 2019 2018 2019 2018 Profit carried forward 1,340.3 1,245.7 1,340.3 1,245.7

TOTAL EQUITY 1,340.3 1,245.7 1,340.3 1,245.7 Surplus capital 13 445.6 406.6 445.6 406.6

TOTAL SUBORDINATE LOAN CAPITAL 445.6 406.6 445.6 406.6

Pension provisions 14 9,238.1 8,546.5 9,238.1 8,546.5

Profit margin on pension provisions 0.0 0.0 0.0 0.0

TOTAL PR0VISIONS FOR PENSION

AGREEMENTS AND INVESTMENT 9,238.1 8,546.5 9,238.1 8,546.5

Debt concerning financial derivatives 9 75.0 176.6 75.0 176.6

Debt to credit institutes 1,334.5 558.8 1,334.5 558.8

Pension return tax payable 67.9 71.6 67.9 71.6

Other debt 25.3 30.0 25.3 30.7

TOTAL DEBT 1,507.4 837.1 1,502.6 837.7

PREPAYMENTS AND ACCRUALS 1.2 0.7 1.2 0.7

TOTAL LIABILITIES 12,532.7 11,036.6 12,527.9 11,037.3

Accounting policies 1

Financial highlights and key ratios for

the last five years 2

Contingencies 15

Affiliated and associated parties 16

Risk and risk management 17

Specification of assets and their

return 18

Page 18: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

18 Annual Report 2019

The Pharmaconomists’ Pension Fund

Equity and Capital Base

All amounts in DKK mill.

Pension Fund Consolidated

Equity 2019 2018 2019 2018

Equity as at 1 January 1,245.7 1,300.8 1,245.7 1,300.8

Transferred to excess capital 0.0 0.0

Transferred from profit distribution 94.6 -55.1 94.6 -55.1

Other total income 0.0 0.0 0.0 0.0

Total equity 1,340.3 1,245.7 1,340.3 1,245.7

Pension Fund Consolidated

Capital base 2019 2018 2019 2018

Equity 1,340.3 1,245.7 1,340.3 1,245.7

Surplus capital 445.6 406.6 445.6 406.6

Total capital base 1,785.9 1,652.3 1,785.9 1,652.3

Page 19: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

19 Annual Report 2019

The Pharmaconomists’ Pension Fund

Notes All amounts in DKK mill.

Note 1 Accounting Policies

The Annual Report for the Group and the Pension Fund has been prepared in accordance with the provi-sions of the Danish Financial Business Act and the executive accounting order from the Danish Financial Supervisory Authority on financial reporting from insurance companies and pension funds.

A few reclassifications have been made under investment return in the Income Statement. The Annual Report is presented in millions of Danish kroner with one decimal. Each figure is rounded off separately. Consequently, variations may exist between the totals and the sum of the underlying figures.

Accounting policies are unchanged from 2018.

Principles regarding the distribution of profits and/or losses In accordance with the executive order on the contribution principle, the Pension Fund has notified the Danish Financial Supervisory Authority of its principle for distributing the result of the year under review. The main principle is that the part of the profit obtained in the year under review and allocated to equity

and surplus capital consists of a yield corresponding to the investment return before pension return tax plus a risk return rate of 0.5% for the unconditionally guaranteed holdings and 0.1% for the conditionally guaranteed holdings on the average pension provisions. Payments to and from equity are deducted from the share of the profit for the year that goes to equity. Losses covered by equity and surplus capital can be retrieved in the subsequent financial year from the collective bonus potentials if possible The shares transferred from collective bonus potentials in the subse-

quent financial year are reported to the Danish FSA. Consolidated Accounts The Consolidated Accounts comprise the Pension Fund and affiliated companies, where the Pension Fund

has a controlling influence. The Consolidated Accounts are made by combining (consolidating) accounting items with a uniform content in the Pension Fund and the affiliated companies.

In consolidation, intra-Group income and costs are eliminated together with intra-Group share holdings and outstandings. Intra-Group services are charged on market terms or cost-covering terms. Intra-Group trading in securities and other investment assets is charged at market value.

Translation of currencies Transactions in foreign currencies are translated at the exchange rate of the transaction date. Balance Sheet items in foreign currencies are translated at the closing exchange rate of the Balance Sheet date. All currency gains and losses are included in the Income Statement under exchange rate regulation. General principles for recognition and measurement

Assets are recognised in the Balance Sheet if future gains are likely to accrue to the company and the value of the asset can be measured reliably. Commitments are recognised in the Balance Sheet if future gains are likely to be paid by the company and the commitment can be measured reliably. The Income Statement recognises all income as it is earned, while costs are recognised by the amounts that concern the financial year under review.

Purchase and sale of financial instruments are recognised on the transaction date and such recognition ends when the right to receive/pay cash flows from the financial asset or liability has expired, or if it has been assigned. Purchase or sales transactions which had not yet been carried out on the Balance Sheet date are recognised in the Income Statement in the form of their loss or gain. In the first recognition, financial instruments are measured at current value. Measurement after first rec-

ognition is made as described under each accounting item below.

Page 20: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

20 Annual Report 2019

The Pharmaconomists’ Pension Fund

General information about accounting estimates and uncertainties of recognition and meas-urement The calculation of the accounting value of certain assets and commitments is made on the basis of meth-ods and with assumptions, which involve the use of accounting estimates. These estimates are made by Management in accordance with the accounting policies defined and on the basis of historical experience and assumptions deemed by Management to be responsible and realistic.

As a result of the nature of these estimates, the assumptions used may turn out to be incomplete, just as unexpected future events or circumstances may arise. This includes the possibility that others may reach other estimates. The most significant estimates made by Management in connection with the calculation of the accounting

value of certain assets and commitments, and the significant estimate uncertainty associated with the preparation of the Financial Statements are the same as in the preparation of the Financial Statements in the previous year. The areas particularly associated with estimates are measuring of the current value of unlisted financial investment assets and commitments regarding pension provisions.

Measuring of pension provisions Determination of the accounting value of pension provisions is associated with an estimate, especially in

regard to the discounting interest rate graph and the assumptions on mortality. The assumptions on the best estimate for disablement are based on the disablement figures observed in recent years. The deter-mination of assumptions is influenced by actuary estimates which are significant to the size of provisions. Current value of unlisted financial investment assets and commitments Investment assets and financial commitments are recognised at current value or amortised cost.

The current value is the price which can be obtained by selling an asset or which is to be paid for the transfer of a commitment in a normal transaction between independent parties at the time of measure-ment. The current value is determined on the basis of the following hierarchy: Level 1 – listed prices: Listed prices (not adjusted) at regulated trading sites in active markets for identical assets, e.g. shares

listed on the stock exchange.

Level 2 – Other observable input than listed prices for activity: As regards financial investment activities where valuations are based on accepted valuation models with observable market data, major estimates are only used to a limited extent in connection with valuation; this applies, for example, to binds that are less liquid and are valued at current value based on modeled market prices, average prices, etc., on the market.

Level 3 – Non-observable input As regards financial investment activities where valuation is only to a smaller extent based on observable market data, the valuation is influenced by estimates. This applies, for example, to investments in in-vestment properties, shares in affiliated and associated companies with investments in real property or direct infrastructure, such as wind farms and solar energy, as well as for investments in unlisted shares, funds, and loans, etc.

Note 10 shows a break-down of investment activities and financial commitments using the current value hierarchy at levels 1-3 calculated at Group level, including a specification of changes of the year in regard

to level 3 activities. Measurement of current value of infrastructure assets

The valuation of infrastructure assets is based on DCF models (Discounted Cash Flow). The current value of future cash flows during the planning period is extrapolated in the models. The long planning period of up to 25 years from when such investments start increases uncertainty about the expected cash flows. The most significant estimates concern the discount rate of interest and the specific, underlying assump-tions for calculating the expected cash flows for each individual investment. The discount rate of interest has been calculated using the cost-of-capital method and consists of a risk-free interest rate plus an illiq-

uidity premium and the expected rate of inflation. As regards such investments and wind farms, the most significant input parameters other than the dis-count rate of interest will be assumptions on the development of electricity prices, electricity production, maintenance costs, and the costs of disposal when the production period ends.

Page 21: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

21 Annual Report 2019

The Pharmaconomists’ Pension Fund

Measuring of the current value of unlisted shares The current value of unlisted shares is based on information from external parties. The Pension Fund has established internal procedures to ensure the quality of the information received. A more detailed de-scription of valuation is offered in the section on shares. Measuring of current value of unlisted financial investment assets via funds

The current value of unlisted financial investment assets via funds is very much based on confirmation from asset managers or the funds themselves, and others, including through reports, which in many cases are prior to the Balance Sheet date. Internal procedures have been established to secure the quality of the information forming part of current value assessments. This means, among other things, that time staggering of accounting data between

the latest report and the Balance Sheet date must be taken into account, just as quantitative analyses and qualitative assessments must be made and the general marketing development since the latest re-port must be assessed. In addition, general follow-up on the quality of received reports is ensured.

Measuring of the current value of unlisted credit investments The current value calculation of unlisted credit investments is based on models and, as far as possible, on observable data, but such valuations are influenced by estimates. The current value calculation is made

both internally by the finance department and by external parties. In internal calculations, the valuation is made by discounting expected future cash flows. The most signif-icant estimates/input parameters are the discounting rates of interest. The calculation of the discounting rate of interest is based on a credit span of liquid credit bonds and estimates regarding the credit quality of the loan plus illiquidity premiums.

In external valuations, the finance department calculates a corresponding own value as verification of the external valuation. This verification value is based on the same approach as the internal calculations and the pertaining estimates. If the verification value is within an acceptable range from the external valua-tion, the external valuation is used. If this is not the case, the external party that made the valuation will be contacted. If no satisfactory explanation of the difference can be given, the price will be adjusted to match the verification value.

No matter is internal or external valuation is used, the development of the credit quality of the specific investment must be addressed, including the quality of any security provided, together with the general market development, which includes the development of interest rates and interest spans in the valuation process. Measuring of current value of investment properties

The current value calculation is made using the DCF model (Discounted Cash Flow). The most significant estimates are associated in particular with the determination of the discounting factor, which consists of a required return from the property, expectations regarding inflation, and assumptions on future cash flows, e.g. in the form of future rent income, renovations carried out, and the level of no occupancy. A more detailed description of valuation is given in the section on investment properties. Income Statement

Gross members’ contributions Gross members’ contribution in the Pension Fund consists of members’ contributions due for January –

November as well as expected members’ contributions for December. Members’ contributions have been reduced by labour market contributions.

Return on investment Income from affiliated and associated companies contains the Pension Fund’s share of the companies’ op-erating results after tax. Income from investment properties consists of the result of property operation before adjustment of prop-erty values. The costs of property administration are deducted from the result.

Interest and dividend, etc., include the interest earned and the dividend received, etc., concerning invest-ment assets in the year under review. Price adjustments consist of realised and unrealised gains on investment assets, including value regulation of investment properties.

Page 22: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

22 Annual Report 2019

The Pharmaconomists’ Pension Fund

Administrative costs related to investment activities include costs associated with the administration of securities, charges for deposits, and fees for external managers. Pension return tax Pension return tax is recognised in the Income Statement by an amount calculated on the basis of the taxable return in the year under review.

Pension return tax is divided between equity and clients. Equity’s share of the pension return tax is calcu-lated on the basis of equity’s share of the result obtained. Pension payments Pension payments consist of processed and paid pensions.

Changes to superannuation provisions This contains the change of the year to superannuation provisions.

Change to surplus capital This contains the change of the year to the surplus capital.

Administrative costs The Pension Fund pays a fixed annual price (rate) per member to PKA A/S for the agreed administrative services; this amount includes salaries and fees to Management and Board. In addition, the Pension Fund and the affiliated companies pay a fixed fraction of a percent of the net asset current value to cover portfolio management.

The rate and the fraction of a percent are determined on market terms. Transferred return on investment Transferred return on investment has been calculated on the basis of the pro rata share of the result ob-tained that goes to equity and is included in the equity investment return item.

Balance Sheet

Assets Investment properties Investment properties are measured at their value on the Balance Sheet date. The current value calcula-tion rests on the DCF model (Discounted Cash Flow) and is based on the calculation of the net cash flow of

the individual period during a ten-year budget period, which is subsequently discounted, as well as a ter-minal value beyond the ten-year budget period, when the expected and normalised long-term income has been determined and valuated using the return-based valuation model. The return requirement is based on an individual assessment of the individual property, including property type and possible uses, location, state of maintenance, contractual matters, tenant or lessee composition, re-letting options, division into owner-occupied flats, year of construction, etc. The return requirement is

determined on the basis of the expectation that the properties could be sold if selling efforts were to be made for a reasonable period of time.

The discounting factor during the budget period for the individual property is set at the return percentage corrected for long-term inflation.

As regards properties under construction where the current value cannot be measured reliably, the value is calculated as costs paid or net realisation value, if lower. The current value of land and leisure properties is based on the latest official cash valuation. The current value of properties with owner-occupied flats, in which the property has been or can be divided into owner-occupied flats, is calculated per property. For each property, a standardised return require-

ment, together with an individual assessment of the speed of release and the price per square metre in case of a current sale. Value adjustments of investment properties are recognised under Price adjustments via the Income Statement.

Page 23: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

23 Annual Report 2019

The Pharmaconomists’ Pension Fund

Shares in affiliated and associated companies Shares in affiliated companies are measured at intrinsic value (the equity method). Using this method, the operating results of affiliated companies are recognised in the Pension Fund Income Statement. The Pen-sion Fund’s profit and equity are thus identical to those of the Group. The accounting results from affiliated companies result from using recognition and measurement methods

identical to the principles used in the Pension Fund.

Shares in associated companies are recognised at the Pension Fund ownership share of the companies’ intrinsic accounting value. The companies’ intrinsic value results from using measurement methods identi-cal to the methods used in the Pension Fund. All regulations are recognised in income from associated companies.

Associated companies are defined as companies that are not affiliated companies, but where the Group’s companies have shares representing more than 20 % of the voting rights, and where considerable influ-ence is exercised over companies’ operational and financial management through representation on the

boards of companies. Associated companies with a negative intrinsic accounting value are measured at zero and any receivables from such companies are impaired by the parent company’s share of the negative intrinsic value to the

extent the amount is deemed to be irrecoverable. If the negative intrinsic accounting value exceeds the amount receivable, the remaining amount is recognised under provisions for commitments to the extent the parent company has a legal or actual commitment to cover the obligations of the company concerned. The underlying assets and liabilities in affiliated and associated companies are based on measurement at current value.

The current value of investment properties owned through affiliated or associated companies is calculated as described in more detail above in the section on ”Investment properties”. The current value of infrastructure assets owned through affiliated or associated companies is calculated as specified in the section on ”Measuring of current value of infrastructure assets”.

Shares Listed shares are measured at the value of stock exchange closing prices on the Balance Sheet date. Unlisted shares is measured at current value based on an individual assessment of the companies with a view to determining the price which such shares are expected to fetch. The valuation is based on infor-mation from external capital managers to a high extent.

The Pension Fund has established internal processes to support the estimates prepared. The shift in tim-ing between reporting and accounting data is thus taken into account by obtaining supplementary infor-mation about price developments. In addition, analyses of valuations are made in relation to external counterparties and in relation to prices determined by an independent financial institution, so as to test and verify the values determined.

Units in mutual trusts Units in mutual trusts are measured at the value of the stock exchange closing prices on the Balance Sheet

date.

Page 24: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

24 Annual Report 2019

The Pharmaconomists’ Pension Fund

Bonds Fixed-interest bonds, convertible bonds and indexed bonds plus index-related adjustments are measured at the value of the stock exchange closing prices on the Balance Sheet date. The current value of drawn bonds is based on the present value of the bonds, which is close to the nominal value of the bonds. Secured loans

Mortgage bonds are measured at a calculated current vale based on the effective interest rate of the claim, or another corresponding price. Other lending Direct property credit is measured at current value, which basically is par. The valuation is checked against current spreads in the market, the borrower’s creditworthiness, and the underlying collateral.

Other direct credit is measured on the basis of external valuation and checked in relation to developments in similar credit risks for both listed and unlisted securities in the market.

Deposits with credit institutes Deposits with credit institutes are deposits and term deposits with credit institutes and are measured at current value.

Derivative financial instruments Derivative financial instruments used for interest risk hedging and other purposes are measured at current value. Instruments with a positive current value are recognised as assets under Derivative financial in-struments, while instruments with a negative current value are recognised under Debt related to derivative financial instruments.

Repurchase/reversal Securities sold as part of a sell and buy-back transaction stay on the Balance Sheet under the various main items, e.g. ”bonds” that carry interest and are subject to security price adjustment. The received amount is recognized and carries interest as debt to the other party to the transaction. Securities acquired as part of a purchase and sell-back transaction are recognized as accounts receivable by the other party, while the return is recognised under interest.

Accounts receivable Accounts receivable are recognised at face value minus value impairments to cover expected losses. Deferred tax assets Deferred tax assets contain the part of the pension return tax to be paid on the return which is not recog-nised in the Pension Fund’s tax base until a subsequent financial year.

Liquid assets Liquid assets are the Pension Fund’s share of operating liquidity held by banks. Liquid assets are measured at current value. Prepayments and accruals Prepayments and accruals recognised under assets consist of receivable interest and costs paid which con-

cern the following financial year. Prepayments and accruals are measured at amortised cost, which normal-ly corresponds to the face value.

Liabilities

Equity The Pension Fund’s equity belongs to the members jointly.

Surplus capital Surplus capital forms part of the base capital on equal terms with equity capital, but over time it accrues to the insured and thus forms part of the provision made for insurance contracts.

Provision for pension agreements and investment contracts Provisions for pension agreements and investment contracts are calculated by the Pension Fund Actuary in charge.

The pension provisions consist of the following elements: Guaranteed Payments, Individual Bonus Poten-

tial, Collective Bonus Potential and Risk Margin.

Page 25: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

25 Annual Report 2019

The Pharmaconomists’ Pension Fund

The pension provision element entitled Guaranteed Payments is calculated in that, for each insurance pol-icy, the market value of the expected, guaranteed payment flows is calculated. The market value is calcu-lated by discounting individual payments using the interest rate calculated by EIOPA, the European super-visory authority, plus a Volatility Adjustment supplement and minus the pension return tax. Guaranteed Payments contain an estimated amount to cover future insurance payments stemming from insurance events which occurred during the financial year, but where no claim had yet been filed on the date of the

Balance Sheet. Individual Bonus Potential contains the value of obligations to grant a bonus on the basis of the amount deposited under the individual insurance policy qualifying for the bonus. Collective Bonus Potential contains the share of the insurance holding of realised results which has been

set aside as a collective provision for the insurance policies qualifying for the bonus. This amount has not yet been ascribed to the individual member. The Risk Margin contains the amount which the Pension Fund must expect to have to pay to another insur-

ance company to take over the risk of settling the holding. As far as possible, the Risk Margin is obtained primarily from the Individual Bonus Potential and subsequently form the Collective Bonus Potential – or alternatively from the capital base. The Risk Margin is calculated in accordance with the Solvency II rules.

The assumptions regarding the best estimate of mortality are based on the FSA benchmark for current mortality, which is adapted to the Pension Fund’s specific situation as regards the observed mortality of the policy holders. In addition, the FSA benchmark for expected life expectancy improvements is integrated. The FSA benchmark is updated annually and the Pension Fund carries out an annual analysis of any devia-tions from the benchmark for current mortality.

The assumptions regarding best estimate of disablement are based observed disablement in recent years

The discounting interest graph and the assumptions on mortality are the assumptions which have the highest effect on the measurement of provisions made. Profit margin The profit margin shows the present value of profit not yet earned by the Pension Fund on insurance poli-cies which are to be recognised in the Income Statement over time. The profit margin is segregated from the pension provisions.

Debt to credit institutes Debt to credit institutes consists of debt regarding repurchase transactions. Repurchase transactions are

securities which are sold, and where together with the sale an agreement has been made for repurchase, which is recognised in the Balance Sheet as if the said securities were still part of holdings. The debt is measured at current value. Current tax commitments Current tax commitments form part of the pension return tax to be paid for the current financial year.

Other items under liabilities Other items under liabilities, which consist of Other provisions, Debt to affiliated companies, and Other debt, are calculated at current value, which normally corresponds to the face value. Contingency obligations

Pledges of investments, warranties given, guarantees, etc., outside insurance are listed in a note to the

Annual Report. Key ratios Key ratios are prepared in accordance with the rules of the Danish FSA’s executive accounting order on financial reports covering insurance companies and occupational pension funds.

Page 26: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

26 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 2

Financial highlights and key ratios for the last five years

Pension Fund 2015 2016 2017 2018 2019

Members' contribution 192 198 195 200 202

Pension payments * -366 -407 -418 -463 -497

Return on investment 195 552 706 -255 1,324

Total pension-related operating costs -8 -8 -9 -3 -3

Result of re-insurance 0 0 0 0 0

Technical result -195 87 154 11 -7

Profit for the year -114 151 284 -55 95

Total provisions for pension agreements * 8,591 8,867 8,955 8,546 9,238

Total equity 1,380 1,439 1,301 1,246 1,340

Total assets 10,067 10,415 10,891 11,037 12,533

Consolidated 2015 2016 2017 2018 2019

Members' contribution 192 198 195 200 202

Pension payments -366 -407 -418 -463 -497

Return on investment 195 552 706 -255 1,324

Total pension-related operating costs -10 -8 -9 -3 -3

Result of re-insurance 0 0 0 0 0

Technical result -195 87 154 11 -7

Profit for the year -114 151 284 -55 95

Total provisions for pension agreements * 8,591 8,867 8,955 8,546 9,238

Total equity 1,380 1,439 1,301 1,246 1,340

Total assets 10,069 10,416 10,891 11,037 12,528

Key ratios ** 2015 2016 2017 2018 2019

Return related to average interest

products * % 2.3 6.6 6.9 -2.4 13.3

Cost on provisions * % 0.1 0.1 0.1 0.0 0.0

Costs per member kr. 1,027 1,044 1,162 411 385

Return on equity after tax % -7.9 10.7 21.2 -4.3 7.3

Return on surplus capital, to which

return as equity is allocated % - - - -2.1 11.2

* The ministerial order on financial statements was changed as from 2016. With reference to Sect.

84 (2) of the ministerial order, it has not been found to the practically possible to change the five-

year overview, so as to make the figures for the period before 2016 in line with the new method.

Consequently, the figures for 2015 are not directly comparable with 2016-2019.

**Key ratios are given here for the Pension Fund, while no key ratios are prepraed for the Group,

since the Group comprises one pension fund only.

Page 27: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

27 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 3 Pension Fund Consolidated

Gross member contributions 2019 2018 2019 2018

Direct insurance with bonus scheme

Member contributions 199.5 194.2 199.5 194.2

Member single premiums 2.9 5.4 2.9 5.4

Total gross member contributions 202.4 199.5 202.4 199.5

Pension agreements

Taken out as part of an employee plan 202.4 199.5 202.4 199.5

Premiums divided into countries:

Denmark 201.1 198.0 201.1 198.0

Other EU countries 1.0 1.3 1.0 1.3

Other countries 0.3 0.2 0.3 0.2

Calculation of number of policy holders

Taken out as part of an employee plan 8,296 8,132 8,296 8,132

Note 4 Pension Fund Consolidated

Price adjustments 2019 2018 2019 2018

Capital investment 5.5 -3.1 5.5 -3.1

Investment fund shares 743.9 -72.9 743.9 -72.9

Bonds 119.5 114.4 119.5 114.4

Other loans 11.6 3.7 11.6 3.7

Derivative financial instruments -200.9 -161.8 -200.9 -161.8

Cash in hand and at bank -4.9 -26.7 -4.9 -26.7

Total price adjustments 674.7 -146.5 674.7 -146.5

Note 5 Pension Fund Consolidated

Change to pension provisions, own acc. 2019 2018 2019 2018

Individual bonus potential 8.5 -157.2 8.5 -157.2

Guaranteed disbursements -659.8 460.3 -659.8 460.3

Risk margin -40.4 105.8 -40.4 105.8

Total change to pension prov., own acc. -691.7 408.9 -691.7 408.9

All contributions are direct insurance with a

bonus right.

The Pension Fund's total number of insured members has been calculated incl. memberships from which

only spouse and children pensions are paid.

Page 28: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

28 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 6 Pension Fund Consolidated

Pension-related operating costs, own acc. 2019 2018 2019 2018

264.4 261.7 264.4 261.7

76.0 75.3 76.0 75.3

54.6 54.1 54.6 54.1

54.6 54.1 54.6 54.1

54.6 54.1 54.6 54.1

54.6 38.3 54.6 38.3

127.6 126.3 127.6 126.3

127.6 126.3 127.6 126.3

814.0 790.2 814.0 790.2

Salaries and fees

functions under Solvency II.

Auditor

Pension Fund Consolidated

2019 2018 2019 2018

Auditor (amounts in thousands of DKK)

Statutory audit of the Financial Statements 234.2 254.0 245.4 254.0

Other assurance engagements 75.7 91.5 75.7 91.5

Total auditor costs 309.9 345.5 321.2 345.5

The Pension Fund's share of audit costs incl. VAT is:

Ann-Mari Damholt Grønbæk (entered

17.04.2018)

The salaries of Management, the Appointed Actuary and the four key functions are not paid by the

Pension Fund.

CEO Peter Damgaard Jensen received total remunerations for all his functions from the administration

company, PKA A/S, in the amount of DKK 4,388,000

Total Board fees

Henrik Klitmøller Rasmussen

Most of the auditor's work comprises all of the pension funds administered by PKA A/S

Jesper Gulev Larsen

Jørgen Moestrup

Detailed information about salaries in the administrative company PKA A/S can be read at pka.dk.

Susanne Engstrøm

Christina Nicolajsen Durick

Susanne Kure

The Pension Fund has no staff other than Management, the Appointed Actuary and the four key

Board fees (amounts in thousands of DKK)

Lisa Wieweg Rosendahl Hermansen

Page 29: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

29 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 7 Pension Fund Consolidated

Realised profit 2019 2018 2019 2018

1,298.4 -274.0 1,298.4 -274.0

-17.3 -4.2 -17.3 -4.2

17.8 17.0 17.8 17.0Market value adjustment -51.7 65.4 -51.7 65.4

Total realised profit 1,247.1 -195.8 1,247.1 -195.8

which is divided into:

Crediting of bonus 367.5 345.3 367.5 345.3

177.5 -26.2 177.5 -26.2

Return for surplus capital 47.5 -8.7 47.5 -8.7

Pension return tax concerning surplus

capital 8.2 -1.6 8.2 -1.6

Transferred to equity 155.1 21.1 155.1 21.1

14.8 -14.2 14.8 -14.2

Change in individual bonus potential 476.5 -511.6 476.5 -511.6

Total distribution 1,247.1 -195.8 1,247.1 -195.8

Movements on equity:

From realised profit 155.1 21.1 155.1 21.1

-60.5 -76.2 -60.5 -76.2

Profit for the year 94.6 -55.1 94.6 -55.1

Missing return, start of year 53.2 113.3 53.2 113.3

0.0 -60.2 0.0 -60.2

-53.2 0.0 -53.2 0.0

0.0 53.2 0.0 53.2

Outlay, equity return as per Section 6

of the executive contribution order:

Outlay account, start of year 0.0 0.0 0.0 0.0

Loss during period, covered by equity,

carried forward for recovery 1.2 0.0 1.2 0.0

Outlay account, equity, end of year 1.2 0.0 1.2 0.0

Note 8 Pension Fund Consolidated

Investment properties 2019 2018 2019 2018

Current value as at 1 January 3.6 3.6 3.6 43.6

Divestments for the year 0.0 0.0 0.0 -40.0

0.0 0.0 0.0 0.0

Total current value 3.6 3.6 8.1 3.6

Transferred to provisions

Pension return tax on return on equity

Realised cost

Pension return tax

Receivable equity return

Value impairment

Adjustment for the year of missing return

Value adjustment for the year at current value

Receivable equity return as per Section 113

of the executive contribution order:

The principles for distribution of the realised profit and for calculation of risk supplement are described

under accounting policies.

Realised interest

Realised risk

Page 30: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

30 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 9

Other financial investment assets

Financial instruments (Pension Fund and Consolidated)

Financial derivatives 2019 Yrs to expiry Principal

Book

value

Swaps 0-1 3,746.0 -19.1

Swaps 1-10 3,323.7 2.6

Swaps +10 924.8 16.6

Forward currency transactions 0-1 6,938.7 9.5

Forward currency transactions +10 0.0 0.0

Afledte finansielle instrumenter 2018 Yrs to expiry Principal

Book

value

Swaps 0-1 1,950.0 34.8

Swaps 1-10 1,862.5 -7.5

Swaps +10 50.6 -1.8

Forward currency transactions 0-1 10,135.9 -112.5

Go to www.pka.dk for a continually updated list of the companies in which the Pension Fund has made

capital investments..

The book value of financial derivaties in the Balance Sheet is gross. The sum of all contracts with

positive value is recognised in assets under the item ”Financial derivatives”.The sum of all contracts

with negative value is recognised in liabilities under the item ”Debt relating to financial derivatives”.

The net assets of the Pension Fund are adminestered by PKA A/S.

The Pension Fund's investment policy takes account of a number of social, environmental and ethical

aspects. The Pension Fund does not invest in companies that deliberately and consistently infringe on

national laws or rules laid down by international organisations and adopted by Denmark. Furthermore,

the Pension Fund does not invest in coal mines and companies that manufacture weapons or tobacco.

Derivative financial instruments are linked to significant conditions in regard to the development of

interest rates, share prices and exchange rates.

Other financial instruments, such as bonds, capital investment, etc., are not linked to any special,

significant conditions or terms that could influence future cash flows.

Page 31: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

31 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 10 Break-down based on valuation of investment assets and financial commitments

Non-Listed Observable observable

prices input input Total

Investment properties 0.0 0.0 8.1 8.1Shares in associated companies 0.0 0.0 284.1 284.1Loans to associated companies 0.0 0.0 0.0 0.0Shares 5.9 0.0 228.8 234.7Investment trust shares 2,423.4 2,023.1 1,010.4 5,456.9Bonds 2,801.4 2,994.3 0.0 5,795.7Other loans granted 0.0 0.0 257.8 257.8Deposits with credit institutes 217.0 27.7 0.0 244.7Derivative financial instruments 0.0 73.3 12.4 85.7 Investment assets at current value 5,447.6 5,118.5 1,801.7 12,367.8

Debt related to derivative financial instruments 0.0 -43.6 -31.4 -75.0Debt to credit institutes 0.0 -1,334.5 0.0 -1,334.5 Financial commitments at current value 0.0 -1,378.0 -31.4 -1,409.5

Valuation based on non-observable input Current value, start of year 1,526.9Transfers to/from other levels 0.0Purchases/Sales net 220.2Value adjustment 23.2 Current value, end of year 1,770.3

Note 11 Pension Fund Consolidated

Guarantees 2019 2018 2019 2018

32.5 401.7 32.5 401.7

25.9 29.5 25.9 29.5

1,333.9 560.4 1,333.9 560.4Guarantees for repurchase agreement

Cash and bonds received as security for the

current value of derivative financial instruments

As security for clearing and for the current

value of derivative financial instruments, the

Pension Fund has deposit bonds with a net

value of

Investment assets and financial commitments are recognised at current value or amortised cost and

calculated at Group level, cf. details in note 1 "Accounting Policies"

Page 32: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

32 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 12Contingent asset

Note 13 Pension Fund ConsolidatedSurplus capital 2019 2018 2019 2018

Surplus capital, start of year 406.6 422.5 406.6 422.5

Payments received 10.6 10.4 10.6 10.4

Disbursements -19.1 -17.7 -19.1 -17.7

47.5 -8.7 47.5 -8.7 Total surplus capital 445.6 406.6 445.6 406.6

Note 14 Pension Fund Consolidated

Pension provisions 2019 2018 2019 2018

Pension provisions, start of year 8,546.5 8,955.3 8,546.5 8,955.3

Profit margin, start of year 0.0 0.0 0.0 0.0

Individual bonus potential applied 511.6 0.0 511.6 0.0

Total pension provisions, start of year 9,058.1 8,955.3 9,058.1 8,955.3

Collective bonus potential, start of year 0.0 0.0 0.0 0.0

Accumulated value adj., start of year -212.9 -272.9 -212.9 -272.9 -212.9 -272.9 -212.9 -272.9

Retrospective provisions, start of year 8,845.2 8,682.4 8,845.2 8,682.4

Gross contribution 202.4 199.5 202.4 199.5

Interest added 349.0 342.7 349.0 342.7

Pension payments -497.1 -463.3 -497.1 -463.3

-3.3 -3.9 -3.3 -3.9

39.3 7.3 39.3 7.3

55.1 51.3 55.1 51.3

8.5 7.3 8.5 7.3

4.2 2.4 4.2 2.4

9,003.3 8,845.2 9,003.3 8,845.2

270.0 212.9 270.0 212.9

Collective bonus potential, end of year 0.0 0.0 0.0 0.0

Total pension provisions, end of year 9,273.3 9,058.1 9,273.3 9,058.1

-35.1 -511.6 -35.1 -511.6

0.0 0.0 0.0 0.0

Total pension provisions 9,238.1 8,546.5 9,238.1 8,546.5

Accumulated value adjustment, end of year

Retrospective provisions, end of year

Profit margin, end of year

The pension fund's insurance is comprised by the contribution principle. However, the pension fund has

adopted other principles for the distribution of profits obtained than what is stated in the Contribution

Order (Order No. 1643 of 14 December 2016). The provisions of the Order are used to the extent they

do not violate the principles of the pension fund. In practice, this means that the pension fund does

not use a group division as stated in Sect. 3 of the Order.

In 2014, Danish VAT practices were changed; certain services to pension funds are no longer subject

to VAT.

Risk gain after addition of risk bonus

Equity-financed services

The Pension Fund has forwarded a request for repayment of incorectly collected VATto the tax

authorities; this awaits processing. It is unclear to which extent the Pension Fund will receive a

repayment, so the size of the total outstanding is unclear.

Cost supplement after addition of cost bonus

Other

Individual bonus potential applied

Share of realised result after PAL tax

Transferred to/from members' capital

Page 33: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

33 Annual Report 2019

The Pharmaconomists’ Pension Fund

Individual Collective

Guaranteed bonus- bonus-

payments potential potential Total

Pension provisions as at 1 January 2019

Calculation interest rate 0,0% 5,529.1 2,375.4 0.0 7,904.5

Calculation interest rate 4,5% 547.4 0.6 0.0 548.0

All groups 6,076.5 2,376.0 0.0 8,452.5

Risk margin, all groups 93.9

Total pension provisions 8,546.5

Individual Collective

Guaranteed bonus- bonus-

payments potential potential Total

Pension provisions as at 31 December 2019

Calculation interest rate 0,0% 6,149.6 2,367.0 0.0 8,516.5

Calculation interest rate 4,5% 586.7 0.6 0.0 587.3

All groups 6,736.3 2,367.5 0.0 9,103.8

Risk margin, all groups 134.3

Total pension provisions 9,238.1

2019 2018 2019 2018

Return

percentage

Return

percentage

Bonus

ratio

Bonus

ratio

Calculation interest rate 0,0% 13.3% -2.4% 27.4% 28.0%

Calculation interest rate 4,5% 13.3% -2.4% 0.2% 0.2%

2019 2018

Average interest rate 13.9% -2.0%

Breakdown of provisions into original base

interest of holdings not comprised by the

contribution principle:

Return on customer funds after costs

before tax divided into products:

Return percentage of bonus ratio for

insurance holdings not comprised by the

contribution principle:

Note 14 continued

Page 34: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

34 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 15 Pension Fund Consolidated

Contingencies 2019 2018 2019 2018

Investment property 3.6 3.6 3.6 3.6

0.5 0.5 0.5 0.5

284.1 250.8 284.1 250.8

Capital participation 245.2 118.6 245.2 118.6

Unit trust shares 4,637.4 4,438.0 4,637.4 4,438.0

Bonds 4,607.8 4,390.8 4,607.8 4,390.8

Secured loans 0.0 0.0 0.0 0.0

Other loans 115.0 77.3 115.0 77.3

Deposits with credit institutes 231.3 94.2 231.3 94.2

Receivable interest 16.2 25.0 16.2 25.0

Total as security for provisions 10,141.2 9,398.8 10,141.2 9,398.8

Investment assets for take-over after

financial year 175.0 0.0 175.0 0.0

Unlisted shares 371.3 129.7 371.3 129.7

Properties 153.7 42.6 153.7 42.6

Infrastructure 26.2 26.0 26.2 26.0

Credit 420.0 104.0 420.0 104.0

971.2 302.3 971.2 302.3

North Sea Infrastructure

Blafa

Zion

El Campo

In October 2018, PKA acquired 49% of two solar panel parks in California. Both solar parks have been

fully extended and were operational on the acquisition date. The Pension Fund has guarateed its pro

rata share of certain operational and decommisioning-related commitments towards Nordea Bank. The

guarantee commitments amounted to USD 0.6 mill. as per the Balance Sheet date.

In October 2018, the Pension Fund concluded an agreement with Vattenfall and Vestas on the

erection of a 353 MW onshore wind farm in Sweden, near Umeå. The Pension Fund's guarantee

commitment as per the balance Sheet date is the remaining pro rata share of the total investment

pledge plus extra operational guarantees totalling DKK 20.9 mill.

As security for insurance-taker provisions, the

following assets have been registered:

Together with Borgland Advisory AS, the Pension Fund invested in a Vestprosess gas and condensate

facility in October 2019.This asset is located in western Norway north-west of Bergen. As part of the

total financing, there is at the Balance Sheet date a commitment of DKK 6.5 mill. for the remaining

purchase sum.

Investment pledges after deduction of

amounts already deposited:

Capital participation in affiliated companies

Capital participation in associated companies

In 2019, the Pension Fund entered an agreement with Longroad and Vestas on the construction of a

353 MW onshore wind turbine farm in the US, in Knox County, Texas. The Pension Fund's guarantee

commitment as per the balance sheet date consists of the remaining pro rata share of the total

investment pledge plus additional operation-related guarantees totalling USD 7.5 mill.

Page 35: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

35 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 16

Affiliated and associated parties, etc.

The Pension Fund holds

shares in the following

affiliated companies: Activity Domicile

Owner-

ship Result Equity

Farmakonomernes

Ejendomsaktieselskab

Investment in land and

buildingsGentofte 100.0% -0.2 10.5

Farmapension A/S Administration Copenhagen 100.0% 0.0 0.5

The Pension Fund holds

shares in the following

associated companies: Activity Domicile

Owner-

ship Result Equity

DEAS Invest I Holding A/S Property administration Frederiksberg 33.3% 101.1 731.7

No affiliated parties hold a decisive influence over the Pension Fund.

Transactions with Board and Management have involved nothing but their remuneration, cf. Note 6.

Pensionskassernes Administration A/S carries out administrative tasks for the Pension Fund. An

administration agreement has been concluded and services are charged on market terms. The

administrative tasks include pension administration and asset management.

Page 36: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

36 Annual Report 2019

The Pharmaconomists’ Pension Fund

Note 17

Risk information

A number of risks are associated with the pension fund's business model.

• Life assurance risks

• Market risks, including interest risks

• Outsourcing risk

The Pension Fund uses outsourcing, which gives rise to a focus on the associated risks. There is a risk

of making a loss if agreements or controls are inadequate. The Pension Fund has concluded an

outsourcing agreement with PKA A/S on full administration. The Board has laid down policies and

guidelines for outsourcing significant fields of activity, determining the rules for additional outsourcing

from PKA A/S to a third party. This ensures satisfactory follow-up in regard to the various

subsuppliers, such as Forca A/S.

In connection with its work on risk and solvency, the Board of Directors has identified the major risks

associated with the business model:

As regards life assurance risks, the biometric risks, which comprise life expectancy improvements and

changes to the number of anticipatory pension recipients, constitute the most significant risks. Based

on the Danish FSA’s life expectancy regimen, etc., the Pension Fund has adjusted its assumptions on

life expectancy of its members.

Market risks are defined as the risk that the market value of assets and liabilities will change as a

result of changes to market conditions. The most significant market risks exists in interest rates,

shares foreign exchange and tangible porperty, as well as in investment in alternative sources of yield.

The Pension Fund manages these risks by ensuring the necessary diversifcation of investments. The

Board has laid down the risk framework for the different classes of assets.

The Pension Fund hedges against interest risks on guaranteed, deferred pensions based on the Board's

adopted interest risk framework. The consequence of interest hedging is that a significant part of the

interest risk between liabilities and assets has been eliminated. A significant part of the assets for

interest cover are interest swaps, where the Pension Fund pays a variable interest rate and receives a

fixed interest rate. These instruments have the same characteristic as the guaranteed, deferred

pensions in the sense that they increase in value if the interest rate goes down and vice versa.

Note 18

Specification of assets and their return

Primo Ultimo

Land and buildings 46.4 22.4 6.4

Listed capital investments 1,942.9 1,806.6 26.6

Unlisted capital investments 499.0 644.1 11.2

Total capital investments 2,441.8 2,450.7 23.4

Government- and mortgage credit bonds 5,215.6 5,749.8 4.1

Indexlinked bonds 0.0 0.0 0.0

Credit bonds and emerging marked bonds 2,431.2 3,347.4 11.3

Loans etc. 131.4 287.8 4.6

Total bonds and loans 7,778.1 9,385.0 6.6

Affiliated companies 0.0 0.0 0.0

Other financial investment assets 252.9 340.8 -9.2

Derivative financial instruments for hedging the

net change of assets and liabilities 48.8 98.9

Return in % is weighted in time based on the current return.

Accounting value Return in %

p.a. before tax

Page 37: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

Tuborg Boulevard 3, 2900 Hellerup - CVR nr. 10 49 68 37

Årsrapport 2019 (regnskabsperiode 1. januar – 31. december)

Pensionskassen for

Farmakonomer

Godkendt på pensionskassens generalforsamling, den 20. april 2020

Dirigent:

Tina Øster Larsen

Page 38: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

2 Årsrapport 2019

Pensionskassen for Farmakonomer

Indholdsfortegnelse

Ledelsesberetning 3

Ledelsespåtegning 10

Den uafhængige revisors revisionspåtegning 11

Resultat- og totalindkomstopgørelse 15

Balance 16

Egenkapital og Kapitalgrundlag 18

Noter 19

Page 39: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

3 Årsrapport 2019

Pensionskassen for Farmakonomer

Ledelsesberetning Pensionskassen for Farmakonomer driver pensionskassevirksomhed. Som medlemmer optager pensions-kassen farmakonomer, der er berettiget og forpligtet til medlemskab af pensionskassen gennem kollektiv

overenskomst eller ansættelsesaftale. Herudover har pensionskassen mulighed for at optage medlemmer, der er ansat i lignende stillinger og med en tilsvarende uddannelse. Pensionskassen har organiseret sin virksomhed med investeringsaktiviteter i tilknyttede virksomheder. Det er imidlertid den samlede pensionskassekoncerns resultater, der har betydning for medlemmets pension. Hovedtallene i denne beretning er derfor præsenteret på koncernbasis medmindre andet fremgår specifikt.

Årets resultat Koncernens resultat for 2019 blev et overskud på 94,6 mio. kr. Overskuddet foreslås af bestyrelsen over-ført til næste år. Medlemsbidrag er på niveau med 2018, mens pesionsydelserne er steget. Pensionskassen er derfor ikke i

vækst, idet pensionsydelserne overstiger medlemsbidragene.

Det samlede afkast før pensionsafkastskat af pensionskassens aktiver blev 13,3%. Årets resultat vurderes at være tilfredsstillende, og pensionskassen er velkonsolideret. Året der gik

Økonomi 2019 var et år, hvor verdensøkonomien var præget af usikkerheden om handelskrigen mellem USA og henholdsvis Kina og Europa. Det bevirkede, at forventningerne til den globale vækst faldt fra 3,6% i 2018 til 3% i 2019. Til trods for usikkerheden om handelskrigen har udviklingen i de økonomiske nøgletal været både positiv

og negativ. Der er således ikke tegn på en egentlig recession i øjeblikket. Det har været medvirkende til, at aktiemarkederne har haft positive afkast. Det globale aktiemarked har således haft et afkast på 22% i

2019. Stigningerne på aktiemarkederne blev også understøttet af de lempelser af pengepolitikken, som både USA og EU foretog i 2019, og som der ikke umiddelbart er nogen tegn på ophør af. I 2019 er renterne faldet med 0,75% i USA og 0,4% i Europa.

De stigende aktier og faldende renter medførte positive afkast på pensionskassens investeringer. Kontorente Pensionskassens kontorente har i 2019 været 4,7 % før skat. Kontorenten er fastsat til 3,54 % før skat for 2020.

Omregningsrente justeret For at sikre stabile og forudsigelige pensioner er omregningsrenten sat ned pr. oktober 2019 fra 4,5 % til 2,75 %. Medlemmer, der får udbetalt alderspension eller førtidspension, har fået mulighed for at fastholde den hidtidige omregningsrente på 4,5 % eller vælge den lavere.

Privat opsparing

Medlemmerne tilbydes mulighed for at oprette en privat opsparing i pensionskassen, som et fleksibelt supplement til arbejdsgiverordningen. Den private opsparing er udbetalingssikret og kan oprettes som aldersopsparing, ratepension og livsvarig alderspension. I 2019 er medlemmerne begyndt at indbetale til frivillig, privat opsparing.

Page 40: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

4 Årsrapport 2019

Pensionskassen for Farmakonomer

Investeringsporteføljen Afkast Det samlede afkast i 2019 blev på 13,3 %, svarende til 1.323,6mio. kr. før skat. De fleste aktivklasser bidrog med positive afkast i 2019. Størst afkast blev opnået på børsnoterede ak-

tier. Samfundsansvar Pensionskassen har med udgangspunkt i FN’s verdensmål og klimaaftalen fra Paris et stærkt fokus på at bekæmpe klimaforandringer, udbrede grøn energi og fremme bæredygtighed. Især syv af verdensmålene agerer som pejlemærker for pensionskassens investeringsstrategi vedr. ansvarlighed.

Politik og retningslinjer for ansvarlige investeringer følger principperne fremsat af FN’s Global Compact. I forbindelse med FN’s Global Compact har pensionskassen vedtaget en yderligere politik for, at der ikke må investeres i kontroversielle våben eller tobak. Endvidere har pensionskassen en ansvarlig skattepolitik og

en politik for aktivt ejerskab. Det aktive ejerskab udøves primært ved løbende at gå i dialog med de selskaber, der bliver investeret i for

at sikre, at de overholder de politikker og retningslinjer, der er vedtaget af bestyrelsen. Dette har til formål at sikre selskabernes langsigtede værdiskabelse, hvorved der skabes størst mulige afkast til medlem-merne. Såfremt et selskab ikke lever op til pensionskassens politikker og retningslinjer, går PKA i dialog med det pågældende selskab. I tilfælde af at der ikke er udsigt til, at selskabet vil forbedre sig på sigt, og forsætter med at agere i strid med politikker og retningslinier, vil det resultere i, at selskabet bliver eksklu-deret fra investeringsuniverset. De selskaber der bliver ekskluderet noteres på en negativliste, og offentlig-gøres på pensionskassen’s hjemmeside, hvor der også findes informationer omhandlende selskaber, der er

under observation og med hvilke, der er dialog. Pensionskasserne investerer ikke i selskaber, hvis samlede eksponering mod kulproduktioner er over 25% og ikke har intention om at ændre sin forretningsmodel således, at den er på linje med Parisaftalens mål-sætninger. For at afklare selskabernes tilgang til Parisaftalen indgår PKA i dialog med selskaber, der har en kuleksponering på over 25%. Dialogen har til formål, at reducere selskabernes aktiviteter indenfor kul og

omdanne disse til mere klimavenlige energikilder. Dette har resulteret i, at pensionskassen i alt har eksklu-

deret 60 kulselskaber, og fortsat er i dialog med 4 selskaber. Der er ligeledes fokus på olie- og gasselskaber, og i hvor høj grad deres forretningsmodel er i overens-stemmelse med klimamålet fremsat ved Paris aftalen. På denne baggrund er der i alt blevet ekskluderet 63 olie- og gasselskaber, og fortsat dialog med 7 selskaber.

I 2019 har der været særligt fokus på transportsektoren, hvor PKA er gået i dialog med 15 selskaber, der tilsammen udgør 3/4 af pensionskassens samlede investeringer i bilsektoren. Ved udgangen af 2019 blev dialogen med selskaberne konkluderet og ét selskab ekskluderet, mens 5 blev sat på observationslisten. PKA følger disse selskaber nøje og vil i slutningen af 2020 vurdere dem på ny. Derudover er PKA en del af det globale investorinitiativ Climate Action 100+, der har til formål at indgå i dialog med de største CO2-udledende selskaber i verden og stille krav til, at de fremlægger forretningspla-

ner, der er på linje med Paris aftalens målsætninger. Initiativet løber indtil 2022, og bestyrelsen besluttede i 2019, at pensionskasssen i 2022 – når initiativet udløber - skal ekskludere de selskaber, der ikke lever op til kravet om bæredygtige forretningsplaner.

Pensionskassen har – i samarbejde med de øvrige pensionskasser i PKA - et ambitiøst mål om, at 10 % af formuen, svarende til samlet set 30 mia. kr. skal være investeret i klimaprojekter ultimo 2020, mod samlet

set 26,5 mia. kr. ved udgangen af 2019. I 2020 vil fokus derfor fortsat være på at foretage grønne inve-steringer, der sikrer gode afkast til medlemmerne. Samtidig har PKA i 2019 lavet en udmelding sammen med andre danske pensionskasser om at investere yderligere 350 mia. kr. i grønne aktiver inden udgangen af 2030. Samtidig møder pensionskassen stadigt større krav til håndtering af klimarelaterede finansielle risici. Pen-sionskassen forventer derfor i 2020 at offentliggøre sin første rapportering, på linje med anbefalingerne fra

Task Force on Climate-Related Financial Disclosures, der skal redegøre for, hvordan klimarisici håndteres i investeringsarbejdet. En af måderne at gøre dette på er at integrere ESG-faktorer i investeringerne, såle-des at selskaber med god opførsel vedr. miljø, arbejdstager- og menneskerettigheder opprioriteres i inve-steringsarbejdet, mens der ikke gås på kompromis med afkastkrav. PKA vurderer, at de selskaber, der har god opførsel på disse parametre over det lange løb skaber bedre afkast og en bedre verden til vores med-lemmer.

Page 41: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

5 Årsrapport 2019

Pensionskassen for Farmakonomer

Samarbejde om investeringer og likvider Pensionskassens formue forvaltes af PKA A/S. Pensionskassen har indgået en aftale med øvrige pensions-kasser, som administreres af PKA A/S om effektiv og rationel styring af investeringer og likvider for at opnå størst muligt afkast og minimering af omkostninger. Afledte finansielle instrumenter

Pensionskassen anvender afledte finansielle instrumenter til investerings- og afdækningsformål. Risici og solvens forbundet med pensionskassens forretningsmodel Pensionskassens forretningsmodel er i et risikoperspektiv simpel. Modellen bygger på en overenskomst-baseret, kollektiv og solidarisk arbejdsmarkedspensionsordning.

De væsentligste risici knytter sig til markedsrisici, forsikringsmæssige risici og outsourcing. Markedsrisici Pensionskassen udbyder et gennemsnitsrenteprodukt. Nye medlemmer optages til en grundlagsrente på

-0,75% pr. 1. januar 2020, ligesom pensionskassen stadig har nogen medlemmer med en rente på 4,50%. Dette medfører en eksponering mod renterisiko, som løbende afdækkes.

Pensionskassen ønsker at levere robuste pensioner til sine medlemmer. Dette sikres ved en langsigtet investeringsstrategi, hvor målet er at opnå høje, stabile afkast på en ansvarlig måde, der som minimum kan honorere afkastkravet fra de udmeldte pensioner. Et vedvarende lavt afkast på investeringsaktiverne eller store finansielle tab er en risiko mod at kunne levere robuste pensioner. Den eksponering er pensi-onskassens markedsrisiko. Risikoen afdækkes ved at sprede investeringerne i en række forskellige aktiv-klasser.

Der investeres kollektivt for medlemmerne. Eventuelle tab på investeringerne skal dækkes af kollektivet, men andelen af bonuspotentialer i pensionskassen sikrer, at eventuelle tab på de finansielle markeder ikke overvæltes til medlemmernes depoter i de enkelte år, men at medlemmerne i stedet får tilskrevet den til enhver tid udmeldte kontorente. Risikotagning er en forudsætning for at opnå et tilstrækkeligt afkast til at sikre robuste pensioner. Det er

i den sammenhæng en væsentlig opgave for bestyrelsen at få fastlagt den ønskede risikoappetit i form af

den valgte investeringsstrategi. Pensionskassens risikoappetit er fastsat ud fra to mål. Pensionskassen beskytter medlemmernes pensio-ner i Risikostyringsmodellen, og pensionskassen overholder gældende solvensregler (SCR). Bestyrelsen fastsætter i sin risikostyringspolitik sikkerhedsniveauerne for grænserne i Risikomodellen, der giver de risikomæssige rammer for pensionskassen i forhold til at beskytte pensionerne. I tillæg kan solvensover-

dækningen i særlige tilfælde sætte rammerne for pensionskassens risikotagning. Pensionskassen har en kapitalplan og en nødplan baseret på risikostyringsmodellen (PBG) samt solvens-kapitalkravet (SCR). I kapitalplanen skønnes den finansielle situation i pensionskassens strategiske plan-lægningsperiode at være betryggende. Forsikringsmæssige risici

Pensionskassen giver livsvarige pensioner, og er således risikomæssigt eksponeret mod ændringer i den forventede levealder blandt medlemmerne.

Pensionskassen er en solidarisk ordning med invaliditetsdækning uden krav om helbredsoplysninger ved optagelse, så længe medlemmet er omfattet af en af de omfattede faggrupper. Pensionskassen er risiko-mæssigt eksponeret mod udviklingen i førtidspensioneringen af medlemmerne.

Pensionskassen overvåger udviklingen i de forsikringsmæssige risici tæt, og hensætter i henhold til Fi-nanstilsynets levetidsbenchmark.

Page 42: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

6 Årsrapport 2019

Pensionskassen for Farmakonomer

Outsourcing Pensionskassen anvender outsourcing i væsentligt omfang. Der er direkte outsourcing til PKA A/S, der igen har videreoutsourcet en stor del af driften til Forca A/S. Administration af ejendomsinvesteringer er outsourcet til DEAS A/S. Fra 2020 er en del af ejendomsadministrationen outsourcet til Newsec. Derudover er en del af fondsadministrationen outsourcet til henholdsvis Forca A/S og Nykredit portefølje-

administration, og fondsforvaltningen er outsourcet til en række porteføljeforvaltere. Risikoen styres i form af kontroller og serviceleveranceaftaler. Kapitalforhold Egenkapitalen er i 2019 øget med 94,6 mio. kr. til 1.340,3 mio. kr. Kapitalgrundlaget udgør herefter

1.785,9 mio. kr. mod 1.652,3 mio. kr. i 2018. Solvenskravet SCR er opgjort efter standardmodellen. Pr. 1. januar 2019 er SCR opgjort til 492,9 mio. kr. og udgør ultimo 2019 561,3 mio. kr.

Nøgletallet Solvensdækning i % udarbejdes alene for pensionskassen, og der udarbejdes ikke nøgletal for koncernen, da denne kun omfatter en pensionskasse. Solvensdækning i % for de sidste fem år er præsen-

teret i nedenstående tabel.

2015 2016 2017 2018 2019

Solvensdækning i % 514 326 321 335 318 Regnskabsbekendtgørelsen er ændret fra og med 2016. Det er ikke fundet praktisk muligt at ændre tallene for perio-den før 2016 til at være i overensstemmelse med den nye metode. Tallene for 2015 er derfor ikke direkte sammenlig-nelige med 2016-2019. Følsomhedsanalysen er præsenteret i pensionskassens Rapport om solvens og finansiel situation (SFCR) 2019, som er tilgængelig på hjemmesiden www.pka.dk.

Bonuspolitik Udgangspunktet for pensionsordningen er, at aftaleparterne har besluttet en kollektiv og solidarisk til-

gang med ensartede pensioner, hvor alle medlemmerne så vidt muligt stilles ens:

• Ingen helbredsoplysninger ved optagelse

• Samme afkast, uafhængigt af optagelsestidspunkt

• Samme pris for forsikringer under hensyn til alder

• Samme pris for administration.

Når bonussatser bliver fastlagt, sker det ud fra denne målsætning og ønsket om at sikre en stabil udvik-ling over tid i medlemmernes pensioner. Bonussatserne skal understøtte bestyrelsens fastlagte investe-ringsstrategi samt de lovmæssige krav til rimelighed og minimumskapital. Den kollektive og solidariske tilgang betyder, at eventuelle underskud, uanset oprindelse, kan dækkes af pensionskassens reserver efter kollektive og solidariske principper. Bonuspotentialer kan fuldt ud anven-

des til at dække medlemmernes andel af et underskud. Dette fremgår af § 1 stk. 2 i pensionskassens bo-nusregulativ. Egenkapitalen i pensionskassen ejes af medlemmerne, og resultatet tilgår i sin helhed altid medlemmerne.

Page 43: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

7 Årsrapport 2019

Pensionskassen for Farmakonomer

Hensættelser til pensionsaftaler Hensættelserne til pensionsaftaler er i 2019 forøget med 692 mio. kr. til 9.238 mio. kr. Hensættelserne er primært påvirket af faldet i den regulatoriske rentekurve. Usikkerhed ved indregning og måling

Ved udarbejdelsen af årsrapporten foretages en række skøn og vurderinger om fremtidige forhold, som har indflydelse på den regnskabsmæssige værdi af aktiver og forpligtelser. De væsentligste områder omfatter de pensionsmæssige forpligtelser samt værdiansættelse af unoterede alternative investeringer og ejendomme. Områderne er de samme som ved udarbejdelse af årsrapporten for 2018.

Ledelsen vurderer, at de anvendte forudsætninger er forsvarlige men forbundet med en vis usikkerhed. Regnskabsmæssige skøn er beskrevet nærmere i note 1 ”Anvendt regnskabspraksis”.

Begivenheder efter balancedagen 30. januar 2020 indgik regeringen en aftale omkring Boligregulerinsglovens §5.2. Aftalen vil indføre en

række initiativer der kan påvirke værdiansættelsen af pensionskassens investeringer i ældre boligejen-domme som er omfattet af mulighederne for 5.2 moderniseringer. Aftalen er ikke endeligt vedtaget og den endelige udformning fortsat behæftet med usikkerhed. Effekten af indgrebet er vurderet til ikke at have væsentligt påvirkning i forhold til pensionskassens værdiansættelse af denne type ejendomme.

De finansielle markeder har i slutningen af februar og starten af marts 2020 reageret kraftigt på udbredel-sen af Covid-19 til Europa, hvor der har været markante aktiefald og de længere renter ligeledes er faldet. Pensionskassen er robust og godt rustet til disse udfordringer gennem en veldiversificeret portefølje. Der har herudover ikke været begivenheder efter statusdagen, som har væsentlig indflydelse på pensions-kassen og koncernens økonomiske forhold.

Forventninger til fremtiden Usikkerheden om væksten vil fortsætte ind i 2020 og præge de finansielle markeder. Flere forhold spiller ind, herunder bl.a. udfaldet af handelskrigen mellem Kina og USA. Storbritannien er udtrådt af EU 31. januar 2020. Frem til udgangen af 2020 skal der forhandles en ny han-delsaftale. Hvis den ikke falder på plads, er det fortsat muligt, at der kommer et ”Hårdt Brexit”, som kan

have store økonomiske konsekvenser for primært Storbritannien, men også EU. Der ses fortsat flere kriser forårsaget af klimaet, senest med de katastrofale brande i Australien. Det påvir-ker i stigende grad den globale økonomi. Effekterne er svære at forudsige, men de vil ofte være store. De finansielle markeder har i slutningen af februar og starten af marts 2020 reageret kraftigt på udbredel-sen af Covid-19 til Europa, hvor der har været markante aktiefald og de længere renter ligeledes er faldet.

Ved tidligere epidemier har der ikke været længerevarende effekter på de finansielle markeder. Det skyl-des, at omfanget af epidemierne har været begrænset, inden epidemierne fik en længerevarende effekt på økonomisk aktivitet. Det forventes, at udbredelsen af Covid-19 vil have en betydende indvirkning på den

globale økonomiske aktivitet på kort og mellemlangt sigt, mens implikationerne på længere sigt er usikre – da dette afhænger af omfanget og varigheden af Covid-19.

Administration Pensionskassen og de tilknyttede virksomheder administreres af PKA A/S. Direktionen og de fire nøglefunktioner under Solvens II er ansat, men ikke aflønnet af pensionskassen.

Page 44: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

8 Årsrapport 2019

Pensionskassen for Farmakonomer

Pensionskassekoncernen Pensionskassens tilknyttede (100 % ejede) virksomheder pr. 31. december 2019 fremgår af koncernover-sigten.

Pensionskassen for Farmakonomer

Farmakonomernes Ejendomsaktieselskab

FarmaPension A/S

Pensionskassens ejendomsaktieselskab Selskabet har til formål at eje og drive fast ejendom med henblik på at opnå langsigtet forrentning af den investerede kapital. Selskabets resultat for 2019 udgør et underskud på 0,2 mio. kr., hvilket er i overensstemmelse med for-ventningerne.

Farmakonomers Ejendomsaktieselskab deltager i interessentskaber sammen med andre ejendomsaktiesel-skaber tilknyttet PKA. Interessentskaberne offentliggør ikke selvstændige årsrapporter under henvisning til bestemmelserne i årsregnskabsloven. Interessentskaberne indarbejdes pro rata i interessenternes årsregn-skaber.

FarmaPenson A/S Selskabet er uden aktivitet. Selskabet har indsendt anmodning om tibagebetaling af uberettiget opkrævet moms for tidligere periode. SKAT har endu ikke startet sagsbehandling. Resultatet for 2019 er 0,0 mio. kr.

Revisionsudvalg I henhold til lovgivningen skal pensionskassen etablere et revisionsudvalg. Formanden skal være uaf-

hængig og mindst et medlem skal have kvalifikationer indenfor regnskabsvæsen eller revision. Formanden for revisionsudvalget er Susanne Kure, som opfylder kravene om både uafhængighed og kva-lifikationer inden for regnskabsvæsen eller revision. Det øvrige medlem af revisionsudvalget er Susanne Engstrøm. Status for opfyldelse af måltal for det underrepræsenterede køn i ledelsen

Der er i lov om finansiel virksomhed krav om, at finansielle virksomheder skal opstille måltal for den køns-mæssige repræsentation i bestyrelsen samt udarbejde en politik for ligerepræsentation i ledelsen af sel-skabet, hvis der er en underrepræsentation af det ene køn i bestyrelsen. Der er underrepræsentation, hvis det ene køn er repræsenteret med mindre end 40% i bestyrelsen. Reglerne om måltal for kønsrepræsentation i bestyrelsen tager udgangspunkt i de generalforsamlings-

valgte medlemmer af bestyrelsen, men i pensionskassen udpeges et flertal af bestyrelsesmedlemmerne af overenskomstparterne. Det bliver på den baggrund ikke retvisende at vedtage måltal for de generalfor-samlingsvalgte medlemmer af bestyrelsen. Bestyrelsen har derfor fastsat et måltal for den kønsmæssige sammensætning af den samlede bestyrelse. Bestyrelsen har besluttet, at måltallet for mænd i bestyrelsen skal være mindst 25% og måltallet for kvin-der i bestyrelsen skal være mindst 40%. Ved årets udgang var den kønsmæssige andel i bestyrelsen så-

dan, at der var 37,5% mænd i bestyrelsen og 62,5% kvinder i bestyrelsen. De opstillede måltal er således opfyldt. Der er ikke vedtaget en politik for ligerepræsentation i ledelseslagene under direktionen i pensionskassen. Pensionskassen totaladministreres af PKA A/S. PKA A/S havde pr. 31. december 2019 46 % kvinder og 54% mænd i ledelseslagene under direktionen, og der er derfor ikke krav om, at der udarbejdes en politik

på området.

Page 45: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

9 Årsrapport 2019

Pensionskassen for Farmakonomer

Ledelseshverv

Direktionens ledelseshverv er følgende:

Administrerende direktør Jon Steingrim Johnsen Adm. direktør i Pensionskassernes Administration A/S Adm. direktør i PKA+ Pension Forsikringsselskab A/S Adm. direktør i fire pensionskasser administreret af PKA A/S Adm. direktør i Sygeplejerskernes og Lægesekretærernes Ejendomsaktieselskab Adm. direktør i Sundhedsfagliges Ejendomsaktieselskab

Adm. direktør i Socialrådgivernes, Socialpædagogernes og Kontorpersonalets Ejendomsaktieselskab Direktør i PKA Ejendomme af 2012 I/S Bestyrelsesformand i A/S Kjøbenhavns Ejendomsselskab Bestyrelsesformand i Forstædernes Ejendomsaktieselskab Bestyrelsesformand i Institutional Holding P/S Bestyrelsesformand i PKA Private Funds III P/S

Bestyrelsesformand i IIP Denmark GP ApS

Bestyrelsesformand i IIP Denmark P/S Bestyrelsesformand i PKA Venture I GP ApS Bestyrelsesformand i Poppelstykket 12 A/S Bestyrelsesformand i Rugårdsvej Odense A/S Bestyrelsesformand i PKA Skejby Komplementar ApS Bestyrelsesformand i PKA Skejby P/S Bestyrelsesformand i Farmapension A/S

Bestyrelsesmedlem i Forca A/S Bestyrelsesmedlem i AIP Management P/S Bestyrelsesmedlem Ringkjøbing Landbobank A/S Bestyrelsens ledelseshverv er følgende:

Bestyrelsesformand Henrik Klitmøller Rasmussen Bestyrelsesmedlem i MP Pension – Pensionskassen for Magistre og Psykologer

Bestyrelsesmedlem i MP Investment Management A/S Bestyrelsesmedlem Jørgen Moestrup Bestyrelsesmedlem i A-Dosispak Komplementar ApS Bestyrelsesmedlem i Danmarks Apotekerforenings Jubilæumsfond

Bestyrelsesmedlem Jesper Gulev Larsen Bestyrelsesformand i Pharmakon A/S Bestyrelsesmedlem i D.A. Invest og Udvikling A/S Bestyrelsesmedlem Susanne Kure, formand for revisionsudvalget Bestyrelsesformand i Changegroup Holding A/S og 1 af selskabets 100 % ejede datterselskaber

Bestyrelsesmedlem og revisionsudvalgsformand i PKA+ Pension Forsikringsselskab A/S Bestyrelsesmedlem og medlem i revisionsudvalget i Pensionskassen for Socialrådgivere, Socialpædagoger og Kontorpersonale Bestyrelsesmedlem i Investeringsselskabet af 24. februar 2015 A/S Bestyrelsesmedlem i Genan Holding A/S

Bestyrelsesmedlem Susanne Engstrøm, medlem revisionsudvalg Øvrige medlemmer af bestyrelsen har ingen yderligere ledelseshverv

Page 46: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

10 Årsrapport 2019

Pensionskassen for Farmakonomer

Ledelsespåtegning Vi har dags dato behandlet og godkendt årsrapporten for regnskabsåret 1. januar – 31. december 2019 for Pensionskassen for Farmakonomer.

Årsrapporten aflægges i overensstemmelse med lov om finansiel virksomhed. Det er vores opfattelse, at koncernregnskabet og årsregnskabet giver et retvisende billede af koncernens og pensionskassens aktiver og passiver og finansielle stilling pr. 31. december 2019 og resultatet af kon-cernens og pensionskassens aktiviteter for regnskabsåret 1. januar – 31. december 2019.

Ledelsesberetningen indeholder efter vores opfattelse et retvisende billede for udviklingen i koncernens og pensionskassens aktiviteter og økonomiske forhold, årets resultater og koncernens og pensionskassens fi-nansielle stilling samt en beskrivelse af væsentlige risici og usikkerhedsfaktorer, som koncernen henholds-vis pensionskassen står over for.

Årsrapporten indstilles til generalforsamlingens godkendelse.

Hellerup, den 23. marts 2020 Direktionen:

Jon Steingrim Johnsen Administrerende direktør

Hellerup, den 23. marts 2020 Bestyrelsen:

Henrik Klitmøller Rasmussen Ann-Mari Damholt Grønbæk Formand

Lise Wieweg Rosendahl Hermansen Susanne Engstrøm

Jesper Gulev Larsen Susanne Kure

Jørgen Moestrup

Page 47: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

11 Årsrapport 2019

Pensionskassen for Farmakonomer

Den uafhængige revisors revisionspåtegning Til medlemmerne i Pensionskassen for Farmakonomer

Konklusion

Det er vores opfattelse, at koncernregnskabet og årsregnskabet giver et retvisende billede af koncernens og pensionskassens aktiver, passiver og finansielle stilling pr. 31. december 2019 samt af resultatet af koncernens og pensionskassens aktiviteter for regnskabsåret 1. januar – 31. december 2019 i overens-stemmelse med lov om finansiel virksomhed. Vores konklusion er konsistent med vores revisionsprotokollat til revisionsudvalget og bestyrelsen.

Hvad har vi revideret Pensionskassen for Farmakonomers koncernregnskab og årsregnskab for regnskabsåret 1. januar – 31. december 2019 omfatter resultat- og totalindkomstopgørelse, balance, egenkapital og kapitalgrundlag,

samt noter, herunder anvendt regnskabspraksis (’regnskabet’)

Grundlag for konklusion

Vi udførte vores revision i overensstemmelse med internationale standarder om revision (ISA) og de yder-ligere krav, der er gældende i Danmark. Vores ansvar ifølge disse standarder og krav er nærmere beskre-vet i revisionspåtegningens afsnit Revisors ansvar for revisionen af regnskabet. Det er vores opfattelse, at det opnåede revisionsbevis er tilstrækkeligt og egnet som grundlag for vores konklusion.

Uafhængighed Vi er uafhængige af koncernen i overensstemmelse med internationale etiske regler for revisorer (IESBA’s Etiske regler) og de yderligere krav, der er gældende i Danmark, ligesom vi har opfyldt vores øvrige etiske forpligtelser i overensstemmelse med IESBA’s Etiske regler. Efter vores bedste overbevisning er der ikke udført forbudte ikke-revisionsydelser som omhandlet i artikel 5, stk. 1, i forordning (EU) nr. 537/2014.

Valg Vi blev første gang valgt som revisor for Pensionskassen for Farmakonomer ved generalforsamlingen den 27. april 2018 for regnskabsåret 2017. Vi er valgt ved en generalforsamlingsbeslutning i en samlet sam-menhængende opgaveperiode på 2 år frem til og med regnskabsåret 2019.

Centrale forhold ved revisionen Centrale forhold ved revisionen er de forhold, der efter vores faglige vurdering var mest betydelige ved vo-res revision af regnskabet for 2019. Disse forhold blev behandlet som led i vores revision af regnskabet som helhed og udformningen af vores konklusion herom. Vi afgiver ikke nogen særskilt konklusion om disse forhold.

Centralt forhold ved revisionen Hvordan vi har behandlet det centrale forhold ved revisionen

Måling af unoterede investeringer

Unoterede investeringer omfatter både investerin-

ger foretaget indirekte via fonde og ved direkte ejerskab. Investeringerne er primært foretaget i in-frastruktur, herunder vindmøller og andre energi-former, erhvervs- og boligejendomme, private equity samt katastrofeforsikringer. Der er i mindre omfang foretaget investeringer i skov og landbrug samt direkte lån til erhvervsvirksomheder

Investeringerne indgår i regnskabsposterne Inve-steringsejendomme, Investeringer i tilknyttede og associerede virksomheder og Andre finansielle inve-steringsaktiver.

Måling af unoterede investeringer

Vi gennemgik og vurderede forretningsgange og in-

terne kontroller for måling af unoterede investerin-ger. Vi vurderede og testede de af ledelsen anvendte værdiansættelsesmodeller. Vi testede stikprøvevis sammenhængen mellem de

anvendte forudsætninger og beregningen af dags-værdier. Herunder foretog vi test af priser rappor-teret af eksterne managers, samt intern opfølgning på priser og markedsudvikling. Vi udfordrede de ledelsesmæssige skøn, der ligger til grund for beregning af dagsværdier ud fra vores

kendskab til porteføljen og markedsudviklingen.

Page 48: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

12 Årsrapport 2019

Pensionskassen for Farmakonomer

Direkte ejede unoterede investeringer måles til en skønnet dagsværdi, der primært er baseret på vær-diansættelsesmodeller og forudsætninger herunder ledelsesmæssige skøn, der ikke er observerbare for

tredjemand. Unoterede investeringer ejet indirekte igennem fonde- og foreninger forvaltet eksternt, måles til en skønnet dagsværdi baseret på rapporteringer fra investeringsforvaltere, supplerende oplysning om prisudviklingen, samt analyser af værdiansættel-

serne. Vi fokuserede på måling af unoterede investeringer, fordi opgørelsen er kompleks og involverer betyde-lige ledelsesmæssige skøn.

Der henvises til koncern- og årsregnskabets omtale

af ’Regnskabsmæssige skøn’ i note 1, ’Investerings-ejendomme’ i note 8, ”opdeling efter værdiansæt-telse af investeringsaktiver og finansielle forpligtel-ser” note 10 samt ’Kapitalandele i associerede virk-somheder’ i note 16.

Måling af pensionshensættelser Pensionskassen har hensættelser til pensionsaftaler og investeringskontrakter for i alt 9.238 mio. kr., hvilket udgør 73,7% af den samlede balance. Hensættelserne består primært af pensionshensæt-

telser til garanterede ydelser, individuelt bonuspo-tentiale, kollektivt bonuspotentiale og risikomargen.

Opgørelsen er baseret på aktuarmæssige principper og involverer væsentlige regnskabsmæssige skøn knyttet til de aktuarmæssige forudsætninger om den tidsmæssige placering og omfang af de fremti-

dige betalinger til forsikringstagerne. De aktuarmæssige forudsætninger omfatter væ-sentligst rentekurve til tilbagediskontering, leveti-der, dødelighed, invaliditet, tilbagekøbssandsynlig-hed og omkostninger.

Vi fokuserede på måling af pensionshensættelser, fordi opgørelsen af hensættelserne er kompleks og involverer betydelige regnskabsmæssige skøn. Der henvises til koncern- og årsregnskabets omtale

af ’Regnskabsmæssige skøn’ i note 1, samt ’Pensi-

onshensættelser’ i note 14.

Vi gennemgik og vurderede de af pensionskassen tilrettelagte forretningsgange og interne kontroller, der er etableret for at sikre, at hensættelser til pen-sionsaftaler og investeringskontrakter måles kor-rekt.

I forbindelse med revisionen anvendte vi vores

egne aktuarer til at vurdere de af pensionskassen anvendte aktuarmæssige modeller og forudsætnin-ger samt de foretagne beregninger, herunder opgø-relser af de fremtidige betalingsstrømme.

Vi vurderede og udfordrede de væsentligste aktu-armæssige forudsætninger såsom rentekurve til til-bagediskontering, levetider, dødelighed, invaliditet, tilbagekøbssandsynlighed samt omkostninger ud fra vores erfaring og branchekendskab med henblik på at vurdere, om disse er i overensstemmelse med

markedspraksis samt regulatoriske og regnskabs-mæssige krav. Dette omfattede en vurdering af kontinuiteten i grundlaget for opgørelsen af hen-sættelser.

Page 49: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

13 Årsrapport 2019

Pensionskassen for Farmakonomer

Udtalelse om ledelsesberetningen Ledelsen er ansvarlig for ledelsesberetningen.

Vores konklusion om regnskabet omfatter ikke ledelsesberetningen, og vi udtrykker ingen form for konklu-sion med sikkerhed om ledelsesberetningen.

I tilknytning til vores revision af regnskabet er det vores ansvar at læse ledelsesberetningen og i den for-bindelse overveje, om ledelsesberetningen er væsentligt inkonsistent med regnskabet eller vores viden op-nået ved revisionen eller på anden måde synes at indeholde væsentlig fejlinformation.

Vores ansvar er derudover at overveje, om ledelsesberetningen indeholder krævede oplysninger i henhold

til lov om finansiel virksomhed.

Baseret på det udførte arbejde er det vores opfattelse, at ledelsesberetningen er i overensstemmelse med koncernregnskabet og årsregnskabet og er udarbejdet i overensstemmelse med kravene i lov om finansiel virksomhed. Vi har ikke fundet væsentlig fejlinformation i ledelsesberetningen.

Ledelsens ansvar for regnskabet Ledelsen har ansvaret for udarbejdelsen af et koncernregnskab og et årsregnskab, der giver et retvisende

billede i overensstemmelse med lov om finansiel virksomhed. Ledelsen har endvidere ansvaret for den interne kontrol, som ledelsen anser for nødvendig for at udarbejde et regnskab uden væsentlig fejlinfor-mation, uanset om denne skyldes besvigelser eller fejl.

Ved udarbejdelsen af regnskabet er ledelsen ansvarlig for at vurdere koncernens og pensionskassens evne til at fortsætte driften; at oplyse om forhold vedrørende fortsat drift, hvor dette er relevant; samt at udarbejde regnskabet på grundlag af regnskabsprincippet om fortsat drift, medmindre ledelsen enten har til hensigt at likvidere koncernen eller pensionskassen, indstille driften eller ikke har andet realistisk alter-

nativ end at gøre dette.

Revisors ansvar for revisionen af koncernregnskabet og årsregnskabet Vores mål er at opnå høj grad af sikkerhed for, om regnskabet som helhed er uden væsentlig fejlinforma-tion, uanset om dette skyldes besvigelser eller fejl, og at afgive en revisionspåtegning med en konklusion. Høj grad af sikkerhed er et højt niveau af sikkerhed, men er ikke en garanti for, at en revision, der udføres i overensstemmelse med ISA og de yderligere krav, der er gældende i Danmark, altid vil afdække væsent-

lig fejlinformation, når sådan findes. Fejlinformationer kan opstå som følge af besvigelser eller fejl og kan betragtes som væsentlige, hvis det med rimelighed kan forventes, at de enkeltvis eller samlet har indfly-delse på de økonomiske beslutninger, som brugerne træffer på grundlag af regnskabet.

Som led i en revision, der udføres i overensstemmelse med ISA og de yderligere krav, der er gældende i Danmark, foretager vi faglige vurderinger og opretholder professionel skepsis under revisionen. Herud-over:

• Identificerer og vurderer vi risikoen for væsentlig fejlinformation i regnskabet, uanset om denne skyldes besvigelser eller fejl, udformer og udfører revisionshandlinger som reaktion på disse risici samt opnår revisionsbevis, der er tilstrækkeligt og egnet til at danne grundlag for vores konklusion. Risikoen for ikke

at opdage væsentlig fejlinformation forårsaget af besvigelser er højere end ved væsentlig fejlinformation forårsaget af fejl, idet besvigelser kan opfatte sammensværgelser, dokumentfalsk, bevidste udeladelser, vildledning eller tilsidesættelse af intern kontrol.

• Opnår vi forståelse af den interne kontrol med relevans for revisionen for at kunne udforme revisions-handlinger, der er passende efter omstændighederne, men ikke for at kunne udtrykke en konklusion om

effektiviteten af koncernens og selskabets interne kontrol.

• Tager vi stilling til, om den regnskabspraksis, som er anvendt af ledelsen, er passende, samt om de regnskabsmæssige skøn og tilknyttede oplysninger, som ledelsen har udarbejdet er rimelige.

• Konkluderer vi, om ledelsens udarbejdelse af regnskabet på grundlag af regnskabsprincippet om fortsat drift er passende, samt om der på grundlag af det opnåede revisionsbevis er væsentlig usikkerhed for-bundet med begivenheder eller forhold, der kan skabe betydelig tvivl om koncernens og pensionskassens evne til at fortsætte driften. Hvis vi konkluderer, at der er en væsentlig usikkerhed, skal vi i vores revisionspåtegning gøre opmærksom på oplysninger herom i regnskabet eller, hvis sådanne oplysninger

ikke er tilstrækkelige, modificere vores konklusion. Vores konklusioner er baseret på det revisionsbevis, der er opnået frem til datoen for vores revisionspåtegning. Fremtidige begivenheder eller forhold kan dog medføre, at koncernen eller pensionskassen ikke længere kan fortsætte driften.

• Tager vi stilling til den samlede præsentation, struktur og indhold af koncernregnskabet og årsregnska-bet, herunder noteoplysningerne, samt om regnskabet afspejler de underliggende transaktioner og be-givenheder på en sådan måde, at der gives et retvisende billede heraf.

• Opnår vi tilstrækkeligt og egnet revisionsbevis for de finansielle oplysninger i virksomhederne eller for-

retningsaktiviteterne i koncernen til brug for at udtrykke en konklusion om koncernregnskabet. Vi er

Page 50: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

14 Årsrapport 2019

Pensionskassen for Farmakonomer

ansvarlige for at lede, føre tilsyn og udføre koncernrevisionen. Vi er eneansvarlige for vores revisions-konklusion.

Vi kommunikerer med den øverste ledelse om bl.a. det planlagte omfang og den tidsmæssige placering af revisionen samt betydelige revisionsmæssige observationer, herunder eventuelle betydelige mangler i in-tern kontrol, som vi identificerer under revisionen.

Vi afgiver også en udtalelse til den øverste ledelse om, at vi har opfyldt relevante etiske krav vedrørende uafhængighed, og oplyser den om alle relationer og andre forhold, der med rimelighed kan tænkes at på-virke vores uafhængighed og, hvor dette er relevant, tilhørende sikkerhedsforanstaltninger. Med udgangspunkt i de forhold, der er kommunikeret til den øverste ledelse, fastslår vi, hvilke forhold der var mest betydelige ved revisionen af regnskabet for den aktuelle periode og dermed er centrale forhold ved revisionen. Vi beskriver disse forhold i vores revisionspåtegning, medmindre lov eller øvrig regulering

udelukker, at forholdet offentliggøres, eller i de yderste tilfælde, hvor vi fastslår, at forholdet ikke skal kommunikeres i vores revisionspåtegning, fordi de negative konsekvenser heraf med rimelighed ville kunne forventes at veje tungere end de fordele, den offentlige interesse har af sådan kommunikation.

København, den 23. marts 2020 PricewaterhouseCoopers

Statsautoriseret Revisionspartnerselskab CVR-nr. 33 77 12 31

Christian Fredensborg Jakobsen Per Rolf Larssen

Statsautoriseret revisor Statsautoriseret revisor

mne16539 mne24822

Page 51: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

15 Årsrapport 2019

Pensionskassen for Farmakonomer

Resultat- og totalindkomstopgørelse

Alle beløb i mio. kr. Pensionskassen Koncernen

Note 2019 2018 2019 2018

Bruttomedlemsbidrag 3 202,4 199,5 202,4 199,5

Medlemsbidrag f.e.r., i alt 202,4 199,5 202,4 199,5

Indtægter fra tilknyttede virksomheder 0,5 2,4

Indtægter fra associerede virksomheder 37,3 37,5 37,3 37,5

Indtægter af investeringsejendomme og

andre materielle investeringsaktiver 0,1 0,1 0,5 2,5

Renteindtægter og udbytter m.v. 624,0 -137,0 624,0 -137,0

Kursreguleringer 4 674,7 -146,5 674,7 -146,5

Renteudgifter -0,8 -1,4 -0,8 -1,4

Administrationsomkostninger i forbindelse

med investeringsvirksomhed -12,2 -9,9 -12,2 -9,9

Investeringsafkast, i alt 1.323,6 -254,7 1.323,6 -254,7

Pensionsafkastskat -200,5 41,9 -200,5 41,9

Udbetalte ydelser -497,1 -463,3 -497,1 -463,3

Pensionsydelser f.e.r., i alt -497,1 -463,3 -497,1 -463,3

Ændring i pensionshensættelser f.e.r.

i alt 5 -691,7 408,9 -691,7 408,9 Ændring i fortjenstmargen 0,0 0,0 0,0 0,0

Ændring i overskudskapital -39,0 15,9 -39,0 15,9

Administrationsomkostninger -3,2 -3,3 -3,2 -3,3

Pensionsmæssige driftsomkostninger

f.e.r. i alt 6 -3,2 -3,3 -3,2 -3,3

Overført investeringsafkast -101,2 66,1 -101,2 66,1

PENSIONSTEKNISK RESULTAT -6,6 11,0 -6,6 11,0

Egenkapitalens investeringsafkast 116,0 -80,3 116,0 -80,3

RESULTAT FØR SKAT 109,4 -69,2 109,4 -69,2

Pensionsafkastskat for egenkapital -14,8 14,2 -14,8 14,2

ÅRETS RESULTAT 94,6 -55,1 94,6 -55,1

ANDEN TOTALINDKOMST 0,0 0,0 0,0 0,0

ÅRETS TOTALINDKOMST 94,6 -55,1 94,6 -55,1

Realiseret resultat 7

Årets resultat overføres til egenkapitalen.

Page 52: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

16 Årsrapport 2019

Pensionskassen for Farmakonomer

Balance

AKTIVER

Alle beløb i mio. kr. Pensionskassen Koncernen

Note 2019 2018 2019 2018

Investeringsejendomme og andre

materielle investeringsaktiver 8 3,6 3,6 8,1 3,6

Kapitalandele i tilknyttede virksomheder 16 11,0 43,4

Kapitalandele i associerede virksomheder 16 284,1 250,8 284,1 250,8

Investeringer i tilknyttede og

associerede virksomheder, i alt 295,1 294,1 284,1 250,8

Kapitalandele 234,7 83,1 234,7 83,1

Investeringsforeningsandele 5.456,9 4.656,6 5.456,9 4.656,6

Obligationer 5.795,7 5.253,5 5.795,7 5.253,5

Andre udlån 257,8 270,8 257,8 270,8

Indlån i kreditinstitutter 243,1 93,2 244,7 137,1

Afledte finansielle instrumenter 9 85,7 89,7 85,7 89,7

Andre finansielle investeringsaktiver,

i alt 12.074,0 10.446,9 12.075,5 10.490,9

INVESTERINGSAKTIVER I ALT 10 12.372,7 10.744,6 12.367,8 10.745,3

Tilgodehavender hos tilknyttede

virksomheder 0,0 0,1

Andre tilgodehavender 0,0 0,0 0,1 0,1

TILGODEHAVENDER, I ALT 0,0 0,1 0,1 0,1 Udskudte skatteaktiver 76,3 207,0 76,3 207,0

Likvide beholdninger 0,1 0,1 0,1 0,1

ANDRE AKTIVER, I ALT 76,4 207,1 76,4 207,1

Tilgodehavende renter 27,4 29,5 27,4 29,5

Andre periodeafgrænsningsposter 56,2 55,3 56,2 55,3

PERIODEAFGRÆNSNINGSPOSTER, I ALT 83,6 84,8 83,6 84,8

AKTIVER I ALT 12.532,7 11.036,6 12.527,9 11.037,3

Opdeling efter værdiansættelse af

investeringsaktiver og finansielle

forpligtelser 10

Sikkerhedsstillelse 11 Eventualaktiv 12

Page 53: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

17 Årsrapport 2019

Pensionskassen for Farmakonomer

Balance

PASSIVER

Alle beløb i mio. kr. Pensionskassen Koncernen

Note 2019 2018 2019 2018 Overført overskud 1.340,3 1.245,7 1.340,3 1.245,7

EGENKAPITAL, I ALT 1.340,3 1.245,7 1.340,3 1.245,7 Overskudskapital 13 445,6 406,6 445,6 406,6

ANSVARLIG LÅNEKAPITAL I ALT 445,6 406,6 445,6 406,6

Pensionshensættelser 14 9.238,1 8.546,5 9.238,1 8.546,5

Fortjenstmargen på pensionshensættelser 0,0 0,0 0,0 0,0

9.238,1 8.546,5 9.238,1 8.546,5

Gæld vedrørende afledte finansielle

instrumenter 75,0 176,6 75,0 176,6

Gæld til kreditinstitutter 1.334,5 558,8 1.334,5 558,8Gæld til tilknyttede virksomheder 4,8 0,0

Aktuelle skatteforpligtelser 67,9 71,6 67,9 71,6

Anden gæld 25,3 30,0 25,3 30,7

GÆLD, I ALT 1.507,4 837,1 1.502,6 837,7

PERIODEAFGRÆNSNINGSPOSTER 1,2 0,7 1,2 0,7

PASSIVER I ALT 12.532,7 11.036,6 12.527,9 11.037,3

Anvendt regnskabspraksis 1

Femårsoversigt over hoved- og

nøgletal 2

Eventualforpligtelser 15

Nærtstående parter m.v. 16

Risikooplysninger 17

Specifikation af aktiver og disses

afkast 18

HENSÆTTELSER TIL PENSIONSAFTALER

OG INVESTERINGSKONTRAKTER, I ALT

Page 54: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

18 Årsrapport 2019

Pensionskassen for Farmakonomer

Egenkapital og Kapitalgrundlag

Alle beløb i mio. kr.

Pensionskassen Koncernen

Egenkapital 2019 2018 2019 2018

Egenkapital pr. 1. januar 1.245,7 1.300,8 1.245,7 1.300,8

Overført fra disponering af årets resultat 94,6 -55,1 94,6 -55,1

Anden totalindkomst 0,0 0,0 0,0 0,0

Egenkapital i alt 1.340,3 1.245,7 1.340,3 1.245,7

Pensionskassen Koncernen

Kapitalgrundlag 2019 2018 2019 2018

Egenkapital 1.340,3 1.245,7 1.340,3 1.245,7

Overskudskapital 445,6 406,6 445,6 406,6

Kapitalgrundlag i alt 1.785,9 1.652,3 1.785,9 1.652,3

Page 55: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

19 Årsrapport 2019

Pensionskassen for Farmakonomer

Noter Alle beløb i mio. kr.

Note 1 Anvendt regnskabspraksis Årsrapporten for koncernen og pensionskassen er udarbejdet i overensstemmelse med bestemmelserne i Lov om finansiel virksomhed og Finanstilsynets Regnskabsbekendtgørelse om finansielle rapporter for for-

sikringsselskaber og tværgående pensionskasser. Der er foretaget enkelte reklassifikationer i resultatopgørelsens investeringsafkast. Årsrapporten præsenteres i millioner kroner med en decimal. Hvert tal afrundes hver for sig. Der kan der-for forekomme afvigelser mellem de anførte totaler og summen af de underliggende tal.

Anvendt regnskabspraksis uændret i forhold til 2018.

Principper for fordeling af over- og underskud Pensionskassen har i overensstemmelse med bekendtgørelse om kontributionsprincippet anmeldt princip for fordeling af årets realiserede resultat til Finanstilsynet.

Hovedprincippet er, at den del af årets realiserede resultat, der tilfalder egenkapitalen og overskudska-pi-tal, består af en forrentning svarende til investeringsafkastet før PAL-skat tillagt risikoforrentning på 0,5 % for de ubetingede garanterede bestand og 0,1 % for de betingede garanterede bestand, af de gennemsnit-lige pensionshensættelser. Betalinger til og fra egenkapitalen fragår i egenkapitalens andel af det realise-rede resultat. Tab, der dækkes af egenkapitalen og overskudskapital, kan hentes i det efterfølgende regnskabsår fra de

kollektive bonuspotentialer, hvis det er muligt. Andelene der overføres fra de kollektive bonuspotentialer i det efterfølgende regnskabsår anmeldes til Finanstilsynet. Koncernregnskabet Koncernregnskabet omfatter pensionskassen og tilknyttede virksomheder, hvor der udøves bestemmende

indflydelse. Koncernregnskabet udarbejdes ved sammenlægning (konsolidering) af pensionskassens og de tilknyttede virksomheders regnskabsposter med ensartet indhold.

Ved konsolidering foretages eliminering af koncerninterne indtægter og omkostninger samt koncerninterne aktiebesiddelser og mellemværender. Koncerninterne ydelser afregnes på markedsbaserede vilkår eller på omkostningsdækkende basis. Kon-cerninterne handler med værdipapirer og andre investeringsaktiver afregnes til markedsværdier.

Omregning af valuta Transaktioner i udenlandsk valuta omregnes til transaktionsdagens valutakurs. Balanceposter i udenlandsk valuta omregnes til balancedagens lukkekurs. Alle valutagevinster og -tab indregnes i resultatopgørelsen under valutakursregulering.

Generelle principper for indregning og måling

Aktiver indregnes i balancen, når det er sandsynligt, at fremtidige fordele vil tilfalde virksomheden, og aktivets værdi kan måles pålideligt. Forpligtelser indregnes i balancen, når det er sandsynligt, at fremti-dige økonomiske fordele vil fragå virksomheden, og forpligtelsen kan måles pålideligt. I resultatopgørelsen indregnes alle indtægter i takt med, at de indtjenes, og alle omkostninger indregnes med de beløb, der vedrører regnskabsåret.

Køb og salg af finansielle instrumenter indregnes på afviklingsdagen, og indregningen ophører, når retten til at modtage/afgive pengestrømme fra det finansielle aktiv eller passiv er udløbet, eller hvis det er over-draget. Købs- eller salgstransaktioner, som på balancedagen endnu ikke er afviklet, indgår i resultatop-gørelsen med deres tab eller avance.

Ved første indregning måles finansielle instrumenter til dagsværdi. Måling efter første indregning sker som beskrevet for hver enkelt regnskabspost nedenfor.

Page 56: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

20 Årsrapport 2019

Pensionskassen for Farmakonomer

Generelt om regnskabsmæssige skøn og usikkerhed ved indregning og måling Opgørelsen af den regnskabsmæssige værdi af visse aktiver og forpligtelser opgøres på baggrund af me-toder med antagelser, der medfører brug af regnskabsmæssige skøn. Disse skøn foretages af ledelsen i overensstemmelse med regnskabspraksis og på baggrund af historiske erfaringer samt forudsætninger, som ledelsen anser som forsvarlige og realistiske.

Som følge af skønnenes natur kan de anvendte forudsætninger vise sig at være ufuldstændige, ligesom uventede fremtidige begivenheder eller omstændigheder kan opstå. Herunder vil andre kunne komme frem til andre skøn. De væsentligste skøn, som ledelsen foretager i forbindelse med opgørelse af den regnskabsmæssige værdi af visse aktiver og forpligtelser, og den væsentlige skønsmæssige usikkerhed forbundet med udar-

bejdelsen af årsregnskabet, er de samme som ved udarbejdelsen af årsregnskabet året før. De områder, der især er forbundet med skøn, er måling af dagsværdi af unoterede finansielle investeringsaktiver samt forpligtelser vedrørende pensionsmæssige hensættelser.

Måling af pensionsmæssige hensættelser Fastlæggelse af den regnskabsmæssige værdi af de pensionsmæssige hensættelser er forbundet med skøn, der især knytter sig til diskonteringsrentekurven og forudsætningerne om dødelighed. Forudsætnin-

gerne om bedste skøn for invaliditet er baseret på den observerede invaliditet i de senere år. Fastlæg-gelse af forudsætningerne er påvirket af aktuarmæssige skøn, der har betydning for hensættelsernes størrelse. Dagsværdi af unoterede finansielle investeringsaktiver og forpligtelser Investeringsaktiver og finansielle forpligtelser er indregnet til dagsværdi eller amortiseret kostpris.

Dagsværdien er den pris, der kan opnås ved salg af et aktiv eller skal betales for overdragelse af en for-pligtelse i en normal transaktion mellem uafhængige parter på målingstidspunktet. Dagsværdien be- stemmes ud fra følgende hierarki: Niveau 1 - noterede priser: Noterede priser (ikke justeret) på regulerede handelspladser i aktive markeder for identiske aktiver, f.

eks. børsnoterede aktier.

Niveau 2 – Andre observerbare input end noterede priser for aktivet: For finansielle investeringsaktiver hvor værdiansættelserne bygger på accepterede værdiansættelsesmo-deller med observerbare markedsdata, er der kun i begrænset omfang væsentlig skøn forbundet med værdiansættelsen, det gælder f. eks. obligationer der er mindre likvide som værdiansættes til dagsværdi ud fra modellerede markedspriser, gennemsnitspriser mv. på markedet.

Niveau 3 – Ikke observerbare input For finansielle investeringsaktiver, hvor værdiansættelsen kun i mindre omfang bygger på observerbare markedsdata, er værdiansættelsen påvirket af skøn. Det gælder bl.a.for investeringer i investeringsejen-domme, kapitalinteresser i tilknyttede og associerede virksomheder med investeringer i ejendomme eller direkte infrastruktur som f.eks. vindmøller og solenergi, samt for investeringer i unoterede aktier, fonde og lån m.m.

Note 10, indeholder en opdeling af investeringsaktiver og finansielle forpligtelser efter dagsværdihierakiet niveau 1-3 opgjort på koncernniveau, herunder en specifikation af årets bevægelser på niveau 3-akti-

verne. Måling af dagsværdi af infrastrukturaktiver

Værdiansættelsen af infrastrukturaktiver bygger på DCF-modeller (Discounted Cash Flow). Nutidsværdien af de fremtidige pengestrømme i planlægningsperioden bliver fremregnet i modellerne. Den lange plan-lægningsperiode, på op til 25 år ved investeringernes start, forøger usikkerheden om de forventede pen-gestrømme. De væsentligske skøn knytter sig til diskonteringsrenten, samt de specifikke underliggende antagelser til opgørelsen af de forventede pengestrømme for hver enkelt investering. Diskonteringsrenten er opgjort

efter en cost of capital metode og sammensætter sig af en risikofri rente med tillæg af en illikviditetspræ-mie og den forventede inflation. For investeringer i f.eks. vindmølleparker vil de væsentligste input parametre udover diskonteringsrenten være antagelser om udviklingen i el-priser, el-produktion, vedligeholdelsesomkostninger samt omkostnin-ger til bortskaffelse ved udløb af produktionsperioden.

Page 57: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

21 Årsrapport 2019

Pensionskassen for Farmakonomer

Måling af dagsværdi af unoterede kapitalandele Dagsværdien af de unoterede kapitalandele er baseret på oplysninger fra eksterne parter. Pensionskas-sen har er etableret interne procedurer, der sikrer kvaliteten af de modtagne oplysninger. For en nær-mere beskrivelse af værdiansættelsen henvises til afsnittet om kapitalandele.

Måling af dagsværdi af unoterede finansielle investeringsaktiver gennem fonde Dagsværdien af de unoterede finansielle investeringsaktiver gennem fonde er i høj grad baseret på oplys-ninger fra kapitalforvaltere eller fondene selv m.fl., herunder ved rapporteringer, som i mange tilfælde ligger forud for balancedagen. Der er etableret interne procedurer, der skal sikre kvaliteten af de oplysninger, der indgår i dagsværdian-

sættelsen. Det indebærer bl.a., at der tages højde for tidsmæssige forskydninger i regnskabsdata mellem seneste rapportering og balancedagen, at der foretages kvantitative analyser og kvalitative vurderinger samt den generelle markedsudvikling siden seneste rapportering vurderes. Der følges derudover generelt op på kvaliteten af den modtagne rapportering.

Måling af dagsværdi af unoteret kreditinvesteringer Dagsværdiberegningen af unoterede kreditinvesteringer er baseret på modeller og i videst muligt omfang

på observerbare data, og værdiansættelserne er påvirket af skøn. Dagsværdiberegningen foretages både internt af finansafdelingen og af eksterne parter. Ved interne beregninger foretages værdiansættelsen ved tilbagediskontering af forventede fremtidige be-talingsstrømme. De væsentligste skøn/input parametre er de anvendte diskonteringsrenter. Beregningen af disse er baseret på kreditspænd på likvide kreditobligationer samt estimater for kreditkvaliteten af lå-net og illikviditetspræmier.

Ved eksterne værdiansættelser beregner finansafdelingen en tilsvarende egen værdi til kontrol af den eksterne værdiansættelse. Kontrolværdien er baseret på samme tilgang som ved egne beregninger og med de dertilhørende skøn. Hvis kontrolværdien er inden for et acceptabelt spænd fra den eksterne vær-diansættelse, benyttes den eksterne værdiansættelse. Hvis dette ikke er tilfældet vil der blive taget kon-takt til den eksterne part, som har foretaget værdiansættelsen. Hvis der ikke kan gives en tilfredsstil-

lende forklaring på forskellen justeres prisen i henhold til kontrolværdien.

Uanset om der benyttes en intern eller ekstern værdiansættelse, skal der tages stilling til udviklingen i kreditkvaliteten på den konkrete investering, herunder kvaliteten af sikkerheder, og den generelle mar-kedsudvikling, herunder udviklingen i renter og rentespænd i værdiansættelsesprocessen. Måling af dagsværdi af investeringsejendomme

Dagsværdiberegningen sker efter DCF-modellen (Discounted Cash Flow) De væsentlige skøn knytter sig især til fastlæggelsen af diskonteringsfaktoren, som sammensætter sig af et afkastkrav til ejendommen, forventninger til inflationen samt antagelserne om de fremtidige pengestrømme, f.eks. fremtidige lejeind-tægter, moderniseringer samt niveauet for tomgang. For en nærmere beskrivelse af værdiansættelsen henvises til afsnittet om investeringsejendomme. Resultatopgørelsen

Bruttomedlemsbidrag Bruttomedlemsbidrag i pensionskassen omfatter forfaldne medlemsbidrag for januar – november og for-

ventede medlemsbidrag for december. Medlemsbidrag er reduceret med arbejdsmarkedsbidrag. Investeringsafkast

Indtægter fra tilknyttede og associerede virksomheder indeholder pensionskassens andel af virksomheder-nes driftsresultater efter skat. Indtægter af investeringsejendomme indeholder resultat af ejendomsdrift før regulering af ejendommenes værdi. I resultatet fragår omkostninger til ejendomsadministration. Renter og udbytter m.v. indeholder regnskabsårets indtjente renter og modtagne udbytter m.v. vedrø-

rende investeringsaktiver. Kursregulering indeholder realiserede og urealiserede gevinster på investeringsaktiver herunder værdire-gulering af investeringsejendomme.

Page 58: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

22 Årsrapport 2019

Pensionskassen for Farmakonomer

Administrationsomkostninger i forbindelse med investeringsvirksomhed, indeholder omkostninger i forbin-delse med værdipapiradministration, depotgebyrer og honorarer til ekstern forvaltning. Pensionsafkastskat Pensionsafkastskat indregnes i resultatopgørelsen med et beløb, der er beregnet på grundlag af regnskabs-årets skattepligtige afkast.

Pensionsafkastskat fordeles mellem egenkapitalen og medlemmerne. Egenkapitalens andel af pensionsaf-kastskat beregnes på baggrund af egenkapitalens andel af realiseret resultat. Udbetalte ydelser Pensionsydelser omfatter ekspederede og udbetalte pensioner.

Ændring i pensionshensættelser Indeholder årets ændring i de pensionsmæssige hensættelser

Ændring i overskudskapital Indeholder årets ændring i overskudskapitalen

Administrationsomkostninger Pensionskassen betaler et årligt fast beløb (tarif) pr. medlem til PKA A/S for de aftalte administrative ydel-ser, hvori indgår lønninger og vederlag til direktion og bestyrelse. Pensionskassen og de tilknyttede virksomheder betaler herudover en fast promillesats af formuens dags-værdi for porteføljepleje.

Tarif og promillesats er fastsat på markedsbaserede vilkår. Overført investeringsafkast Overført investeringsafkast er beregnet på grundlag af egenkapitalens andel af det realiserede resultat og indregnes i posten Egenkapitalens investeringsafkast.

Balancen

Aktiver Investeringsejendomme Investeringsejendomme måles til dagsværdi på balancedagen. Dagsværdiberegningen efter DCF-modellen (Discounted Cash Flow) tager udgangspunkt i opgørelse af den enkelte periodes nettopengestrøm i en ti-

årig budgetperiode, som herefter tilbagediskonteres, samt en terminalværdi udover den 10 årige budget-periode, hvor den forventede og normaliserede langsigtede indtægt er fastlagt og værdiansættes efter den afkastbaserede værdiansættelsesmodel. Afkastkravet bygger på en individuel vurdering af den enkelte ejendom, herunder ejendomstype og anven-delsesmuligheder, beliggenhed, vedligeholdelsesstand, kontraktforhold, lejersammensætning, genudlej-ningsmuligheder, opdeling i ejerlejligheder, opførelsesår mv. Afkastkravet er fastsat ud fra en forventning

om at ejendommene vil kunne afhændes med salgsbestræbelser i en rimelig tidsperiode. Diskonteringsfaktoren i budgetperioden for de enkelte ejendomme fastsættes til afkastprocenten korrigeret

for den langsigtede inflation. For ejendomme under opførelse hvor dagsværdien ikke kan opgøres pålideligt, opgøres værdien som

medgåede omkostninger eller en lavere nettorealisationsværdi. Dagsværdien for grunde og fritidshuse er baseret på den seneste offentlige kontantvurdering. Dagsværdien for ejerlejlighedsejendomme, hvor ejendommen er eller kan opdeles i ejerlejligheder, opgø-res pr. ejendom. For hver ejendom anvendes et standardiseret afkastkrav samt en individuel vurdering af frigørelsestakten og kvadratmeterpriser ved aktuelle salg.

Værdireguleringer på investeringsejendomme indregnes i posten Kursreguleringer over resultatopgørelsen.

Page 59: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

23 Årsrapport 2019

Pensionskassen for Farmakonomer

Kapitalandele i tilknyttede og associerede virksomheder Kapitalandele i tilknyttede virksomheder måles til indre værdi (equity-metoden). Efter denne metode bliver de tilknyttede virksomheders driftsresultater indregnet i pensionskassens resultatopgørelse. Pensionskas-sens resultat og egenkapital er herefter identiske med koncernens. Regnskabsresultaterne fra de tilknyttede virksomheder fremkommer ved anvendelse af indregnings- og

målingsmetoder, der er identiske med de principper, der er anvendt i pensionskassen. Kapitalandele i associerede virksomheder indregnes med pensionskassens ejerandel af virksomhedernes regnskabsmæssige indre værdi. Virksomhedernes indre værdi fremkommer ved anvendelse af målingsme-toder, der er identiske med de metoder, der er anvendt i pensionskassen. Alle reguleringer indregnes i ind-tægter fra associerede virksomheder.

Som associerede virksomheder betragtes virksomheder, som ikke er tilknyttede virksomheder, men hvori koncernens virksomheder har andele på mere end 20 % af stemmerettighederne, og hvor der udøves be-tydelig indflydelse på virksomhedernes driftsmæssige og finansielle ledelse gennem repræsentation i virk-

somhedernes bestyrelser. Associerede virksomheder med negativ regnskabsmæssig indre værdi måles til nul, og et eventuelt tilgo-

dehavende hos disse virksomheder nedskrives med moderselskabets andel af den negative indre værdi, i det omfang det vurderes uerholdeligt. Såfremt den regnskabsmæssige negative indre værdi overstiger til-godehavendet, indregnes det resterende beløb under hensatte forpligtelser, i det omfang modervirksomhe-den har en retlig eller faktisk forpligtelse til at dække den pågældende virksomheds forpligtelser. De underliggende aktiver og passiver i tilknyttede og associerede virksomheder er baseret på måling til dagsværdier.

Dagsværdien af investeringsejendomme ejet gennem tilknyttede eller associerede virksomheder opgøres som nærmere beskrevet ovenfor under afsnittet ”Investeringsejendomme”. Dagsværdien af infrastrukturaktiver ejet gennem tilknyttede eller associerede virksomheder opgøres jf. afsnittet ”Måling af dagsværdi af infrastrukturaktiver”.

Kapitalandele Børsnoterede kapitalandele måles til dagsværdi baseret på børsnoterede lukkekurser på balancedagen. Unoterede kapitalandele måles til dagsværdi baseret på en individuel vurdering af virksomhederne, med henblik på at fastsætte den pris, som kapitalandelene skønnes at kunne handles til. Værdiansættelsen er i høj grad baseret på oplysninger fra eksterne kapitalforvaltere.

Pensionskassen har etableret interne processer, der skal understøtte de udarbejdede skøn. Der tages så-ledes højde for tidsmæssige forskydninger mellem rapportering og regnskabsdata ved at indhente sup-plerende oplysning om prisudviklingen. Derudover foretages der analyser af værdiansættelserne i forhold til eksterne modparter og i forhold til pri-ser fastsat af en uafhængig finansiel institution for at vurdere og efterprøve de fastsatte værdier

Investeringsforeningsandele Investeringsforeningsandele måles til dagsværdi baseret på børsnoterede lukkekurser på balancedagen.

Obligationer Fastforrentede obligationer, konvertible obligationer og indeksobligationer med tillæg af indeksreguleringer

måles til dagsværdi baseret på børsnoterede lukkekurser på balancedagen. Dagsværdien af udtrukne obli-gationer baseres på obligationernes nutidsværdi, der tilnærmelsesvis udgør obligationernes nominelle værdi. Pantsikrede udlån Pantebreve måles til en beregnet dagsværdi baseret på fordringens effektive rente, eller anden tilsvarende kurs.

Andre udlån Direkte ejendomskredit måles til dagsværdi, hvilket som udgangspunkt er kurs pari. Værdiansættelsen kontrolleres i forhold til aktuelle spreads i markedet, låntagers kreditværdighed samt det bagvedliggende kollateral.

Page 60: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

24 Årsrapport 2019

Pensionskassen for Farmakonomer

Øvrig direkte kredit måles med udgangspunkt i ekstern værdiansættelse og kontrolleres i forhold til udvik-lingen i lignende kreditrisiko for både noterede og unoterede værdipapirer i markedet. Indlån i kreditinstitutter Indlån i kreditinstitutter er indeståender og aftaleindskud i kreditinstitutter og måles til dagsværdi.

Afledte finansielle instrumenter Afledte finansielle instrumenter, anvendt til renterisikoafdækning og andre formål, måles til dagsværdi. In-strumenter med positiv dagsværdi indregnes som aktiver under Afledte finansielle instrumenter og instru-menter med negativ dagsværdi indregnes under Gæld vedrørende afledte finansielle instrumenter. Repo/reverse

Værdipapirer, der er solgt som led i salgs- og tilbagekøbsforretninger, beholdes i balancen under den re-spektive hovedpost f.eks. ”obligationer” som forrentes og kursreguleres. Det modtagne beløb indregnes og forrentes som gæld til modparten. Værdipapirer erhvervet som led i købs- og tilbagesalgsforretninger op-tages som tilgodehavender hos modparten og afkastet indregnes under renter.

Tilgodehavender Tilgodehavender optages til pålydende værdi med fradrag af nedskrivning for forventede tab.

Udskudte skatteaktiver Udskudte skatteaktiver indeholder den del af pensionsafkastskatten, som hviler på det afkast, der først indregnes i pensionskassens skattegrundlag i et efterfølgende regnskabsår. Likvide beholdninger Likvide beholdninger består af pensionskassens andel af indestående driftslikviditet i pengeinstitutter. Li-

kvide beholdninger måles til dagsværdi. Periodeafgrænsningsposter Periodeafgrænsnigsposter indregnet under aktiver omfatter tilgodehavende renter samt afholdte omkost-ninger vedrørende efterfølgende regnskabsår. Periodeafgrænsningsposter måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi.

Passiver Egenkapital Pensionskassens egenkapital tilhører medlemmerne kollektivt. Overskudskapital

Overskudskapital indgår i basiskapitalen på lige fod med egenkapitalen, men tilfalder over tid de forsikrede og er dermed en del af hensættelsen til forsikringskontrakter. Hensættelser til pensionsaftaler og investeringskontrakter Hensættelser til pensionsaftaler og investeringskontrakter opgøres af pensionskassens ansvarshavende ak-tuar.

Pensionshensættelserne består af elementerne Garanterede ydelser, Individuelt bonuspotentiale, Kollektivt bonuspotentiale og Risikomargen.

Pensionshensættelsernes element Garanterede ydelser opgøres ved, for hver forsikring, at opgøre mar-keds-værdien af de forventede garanterede betalingsstrømme. Markedsværdien beregnes ved at diskon-tere de enkelte betalinger med den af den europæiske tilsynsmyndighed EIOPA opgjorte rente med VA-tillæg, reduceret med pensionsafkastskat. Garanterede ydelser indeholder et skønnet beløb til dækning af

fremtidige forsikringsydelser, som stammer fra forsikringsbegivenheder indtruffet i regnskabsåret, men som endnu ikke var anmeldt på balancedagen. Individuelt bonuspotentiale indeholder værdien af forpligtelser til at yde bonus på baggrund af det enkelte bonusberettigede forsikringsdepot. Kollektivt bonuspotentiale indeholder forsikringsbestandens andel af realiserede resultater, som er hensat

kollektivt til de bonusberettigede forsikringer. Beløbet er endnu ikke tilskrevet det enkelte medlem. Risikomargen indeholder det beløb, som pensionskassen forventeligt vil skulle betale en anden forsikrings-virksomhed for, at denne vil overtage risikoen for at afvikle bestanden. Risikomargen indhentes så vidt

Page 61: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

25 Årsrapport 2019

Pensionskassen for Farmakonomer

muligt af forsikringernes individuelle dernæst kollektive bonuspotentiale – eller subsidiært kapitalgrundla-get. Risikomargen opgøres i henhold til Solvens II-reglerne.

Forudsætningerne om bedste skøn for dødelighed er baseret på Finanstilsynets benchmark for den aktuelle dødelighed, der tilpasses pensionskassens specifikke forhold vedrørende forsikringsbestandens observe-rede dødelighed. I tillæg hertil indregnes Finanstilsynets benchmark for forventede levetidsforbedringer.

Finanstilsynets benchmarks opdateres årligt, og pensionskassen gennemfører årligt en analyse af eventu-elle afvigelser fra benchmark for den aktuelle dødelighed.

Forudsætningerne om bedste skøn for invaliditet er baseret på den observerede invaliditet i de senere år.

Diskonteringsrentekurven og forudsætningerne om dødelighed er de forudsætninger, der har størst effekt på målingen af hensættelserne. Fortjenstmargen

Fortjenstmargen angiver nutidsværdien af pensionskassens endnu ikke indtjente fortjeneste på forsikrin-gerne, som forventes indregnet i resultatopgørelsen med tiden. Fortjenstmargen udskilles af pensions-

hensættelserne.

Gæld til kreditinstitutter Gæld til kreditinstitutter omfatter gæld vedrørende repoforretninger. Repoforretninger, er solgte værdipa-pirer, hvor der samtidig med salget er indgået aftale om tilbagekøb og indregnes i balancen, som om vær-dipapirerne fortsat var en del af beholdningen. Gælden måles til dagsværdi.

Aktuelle skatteforpligtelser Aktuelle skatteforpligtelser er den del af pensionsafkastskatten der skal betales for det indeværende regn-skabsår. Øvrige poster i passiverne Øvrige poster i passiverne, der omfatter Andre hensættelser, Gæld til tilknyttede virksomheder og Anden gæld, opgøres til dagsværdi, der sædvanligvis svarer til nominel værdi.

Eventualforpligtelser

Tilsagn om investeringer, afgivne garantier og kautioner mv. uden for forsikringsforhold er anført i en note til årsrapporten. Nøgletal

Nøgletal udarbejdes efter reglerne i Finanstilsynets Regnskabsbekendtgørelse om finansielle rapporter for forsikringsselskaber og tværgående pensionskasser.

Page 62: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

26 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 2

Femårsoversigt over hoved- og nøgletal

Pensionskassen 2015 2016 2017 2018 2019

Medlemsbidrag 192 198 195 200 202

Pensionsydelser * -366 -407 -418 -463 -497

Investeringsafkast 195 552 706 -255 1.324

Pensionsmæssige driftsomkostninger, i alt -8 -8 -9 -3 -3

Resultat af afgiven forretning 0 0 0 0 0

Pensionsteknisk resultat -195 87 154 11 -7

Årets resultat -114 151 284 -55 95

Hensættelser til pensionsaftaler i alt * 8.591 8.867 8.955 8.546 9.238

Egenkapital, i alt 1.380 1.439 1.301 1.246 1.340

Aktiver, i alt 10.067 10.415 10.891 11.037 12.533

Koncernen 2015 2016 2017 2018 2019

Medlemsbidrag 192 198 195 200 202

Pensionsydelser -366 -407 -418 -463 -497

Investeringsafkast 195 552 706 -255 1.324

Pensionsmæssige driftsomkostninger, i alt -10 -8 -9 -3 -3

Resultat af afgiven forretning 0 0 0 0 0

Pensionsteknisk resultat -195 87 154 11 -7

Årets resultat -114 151 284 -55 95

Hensættelser til pensionsaftaler i alt * 8.591 8.867 8.955 8.546 9.238

Egenkapital, i alt 1.380 1.439 1.301 1.246 1.340

Aktiver, i alt 10.069 10.416 10.891 11.037 12.528

Nøgletal ** 2015 2016 2017 2018 2019

Afkast relateret til

gennemsnitsrenteprodukter * % 2,3 6,6 6,9 -2,4 13,3

Omkostninger af hensættelser * % 0,1 0,1 0,1 0,0 0,0

Omkostninger pr. medlem kr. 1.027 1.044 1.162 411 385

Egenkapitalforrentning efter skat % -7,9 10,7 21,2 -4,3 7,3

Forrentning af overskudskapital, der

tildeles afkast som egenkapital % - - - -2,1 11,2

* Regnskabsbekendtgørelsen er ændret fra og med 2016. Med henvisning til bekendtgørelsens § 84,

stk. 2 er det ikke fundet praktisk muligt at ændre femårsoversigten, således at tallene for perioden før

2016 bliver i overensstemmelse med den nye metode. Tallene for 2015 er derfor ikke direkte

sammenlignelige med 2016-2019.

** Nøgletal her angives for Pensionskassen, og der udarbejdes ikke nøgletal for koncern, da denne

kun omfatter én pensionskasse.

Page 63: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

27 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 3 Pensionskassen Koncernen

Bruttomedlemsbidrag 2019 2018 2019 2018

Direkte forsikring med bonusordning

Medlemsbidrag 199,5 194,2 199,5 194,2

Medlemsindskud 2,9 5,4 2,9 5,4

Bruttomedlemsbidrag i alt 202,4 199,5 202,4 199,5

Pensionsaftaler

Tegnet i ansættelsesforhold 202,4 199,5 202,4 199,5

Præmier fordelt på lande

Danmark 201,1 198,0 201,1 198,0

Andre EU-lande 1,0 1,3 1,0 1,3

Øvrige lande 0,3 0,2 0,3 0,2

Opgørelse af antal forsikrede

Tegnet i ansættelsesforhold 8.296 8.132 8.296 8.132

Tegnet privat 6 0 6 0

Note 4 Pensionskassen Koncernen

Kursreguleringer 2019 2018 2019 2018

Kapitalandele 5,5 -3,1 5,5 -3,1

Investeringsforeningsandele 743,9 -72,9 743,9 -72,9

Obligationer 119,5 114,4 119,5 114,4

Andre udlån 11,6 3,7 11,6 3,7

Afledte finansielle instrumenter -200,9 -161,8 -200,9 -161,8

Likvide beholdninger -4,9 -26,7 -4,9 -26,7

Kursreguleringer i alt 674,7 -146,5 674,7 -146,5

Note 5 Pensionskassen Koncernen

Ændring i pensionshensættelser f.e.r. i alt 2019 2018 2019 2018

Individuel bonuspotentiale 8,5 -157,2 8,5 -157,2

Garanterede ydelser -659,8 460,3 -659,8 460,3

Risikomargen -40,4 105,8 -40,4 105,8

Ændring i pensionshensættelser f.e.r. i alt -691,7 408,9 -691,7 408,9

Samtlige bidrag er direkte forsikring med ret til

bonus.

Pensionskassens samlede antal forsikrede medlemmer er opgjort incl. medlemskaber, hvorfra der kun

udbetales børnepensioner.

Page 64: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

28 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 6 Pensionskassen Koncernen

Pensionsmæssige driftsomkostninger f.e.r. 2019 2018 2019 2018

264,4 261,7 264,4 261,7

76,0 75,3 76,0 75,3

54,6 54,1 54,6 54,1

54,6 54,1 54,6 54,1

54,6 54,1 54,6 54,1

54,6 38,3 54,6 38,3

127,6 126,3 127,6 126,3

127,6 126,3 127,6 126,3

814,0 790,2 814,0 790,2

Løn

Revisor

Pensionskassen Koncernen

2019 2018 2019 2018

Revisor (beløb i tusinde kr.)

Lovpligtig revision af årsregnskabet 234,2 254,0 245,4 254,0

Andre erklæringsopgaver med sikkerhed 75,7 91,5 75,7 91,5

Samlede revisoromkostninger 309,9 345,5 321,2 345,5

og de fire nøglefunktioner under Solvens II.

Nærmere oplysninger om aflønning i administrationsfællesskabet PKA kan ses på pka.dk.

Susanne Engstrøm

Christina Nicolajsen Durick

Susanne Kure

Der er ingen ansatte i pensionskassen ud over direktionen, den ansvarshavende aktuar

Honorar til bestyrelsen (beløb i tusinde kr.)

Henrik Klitmøller Rasmussen

Jesper Gulev Larsen

Jørgen Moestrup

Ann-Mari Damholt Grønbæk (indtrådt

17.04.2018)

Lisa Wieweg Rosendahl Hermansen

Revisors arbejde sker i stort omfang fælles for de af PKA A/S administrerede pensionskasser.

Samlet honorar til bestyrelsen

Direktionen, den ansvarshavende aktuar og de fire nøglefunktioner er ikke aflønnet af pensionskassen.

Administrerende direktør Peter Damgaard Jensen har modtaget et samlet vederlag for alle sine

funktioner fra administrationsselskabet PKA A/S på i alt 4.388 t. kr.

Pensionskassens andel af revisoromkostningerne inklusive moms udgør:

Page 65: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

29 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 7 Pensionskassen Koncernen

Realiseret resultat 2019 2018 2019 2018

1.298,4 -274,0 1.298,4 -274,0

-17,3 -4,2 -17,3 -4,2

17,8 17,0 17,8 17,0Markedsværdiregulering -51,7 65,4 -51,7 65,4

Realiseret resultat i alt 1.247,1 -195,8 1.247,1 -195,8

som er fordelt til:

Tilskrivning af bonus 367,5 345,3 367,5 345,3

177,5 -26,2 177,5 -26,2

Forrentning til overskudskapital 47,5 -8,7 47,5 -8,7

Pensionsafkastskat vedrørende

overskudskapital 8,2 -1,6 8,2 -1,6

Overført til egenkapitalen 155,1 21,1 155,1 21,1

14,8 -14,2 14,8 -14,2

476,5 -511,6 476,5 -511,6

Fordelt i alt 1.247,1 -195,8 1.247,1 -195,8

Bevægelser på egenkapitalen:

Fra realiseret resultat 155,1 21,1 155,1 21,1

-60,5 -76,2 -60,5 -76,2

Årets resultat 94,6 -55,1 94,6 -55,1

Manglende forrentning primo 53,2 113,3 53,2 113,3

0,0 -60,2 0,0 -60,2

-53,2 0,0 -53,2 0,0

0,0 53,2 0,0 53,2

Udlægskonto primo 0,0 0,0 0,0 0,0

Tab i perioden dækket af egenkapital som

fremføres til indhentning 1,2 0,0 1,2 0,0

1,2 0,0 1,2 0,0

Note 8 Pensionskassen Koncernen

Investeringsejendomme 2019 2018 2019 2018

Dagsværdi pr. 1. januar 3,6 3,6 3,6 43,6

Tilgang i året 0,0 0,0 4,5 0,0

Afgang i året 0,0 0,0 0,0 -40,0

Dagsværdi i alt 3,6 3,6 8,1 3,6

Tilgodehavende egenkapitalforrentning

Ændring i individuel bonuspotentiale

Nedskrivning

Årets regulering af manglende forrentning

Udlægskonto, egenkapital ultimo

Tilgodehavende egenkapitalforrentning i

henhold til § 13 i

kontributionsbekeændtgørelsen:

Udlæg egenkapitalforrentning i henhold til

§ 6 i kontributionsbekeændtgørelsen:

Principperne for deling af det realiserede resultat samt beregning af risikotillæg er beskrevet i anvendt

regnskabspraksis.

Renteresultat

Risikoresultat

Overført til hensættelser

Pensionsafkastskat vedrørende egenkapitalen

Omkostningsresultat

Pensionsafkastskat

Page 66: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

30 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 9

Andre finansielle investeringsaktiver

Pensionskassens formue forvaltes af PKA A/S.

Finansielle instrumenter (Pensionskassen og Koncernen)

Afledte finansielle instrumenter 2019 År til udløb Hovedstol

Bogført

værdi

Swaps 0-1 3.746,0 -19,1

Swaps 1-10 3.323,7 2,6

Swaps +10 924,8 16,6

Valutaterminsforretninger 0-1 6.938,7 9,5

Valutaterminsforretninger 1-10 39,8 1,1

Afledte finansielle instrumenter 2018 År til udløb Hovedstol

Bogført

værdi

Swaps 0-1 1.950,0 34,8

Swaps 1-10 1.862,5 -7,5

Swaps +10 50,6 -1,8

Valutaterminsforretninger 0-1 10.135,9 -112,5

På www.pka.dk kan ses en løbende opdateret liste over de virksomheder, som pensionskassen har

kapitalandele i.

Den bogførte værdi af afledte finansielle instrumenter i balancen sker brutto. Summen af alle kontrakter

med positiv værdi føres i aktiverne under posten ”Afledte finansielle instrumenter”. Summen af alle

kontrakter med negativ værdi føres i passiverne under posten ”Gæld vedrørende afledte finansielle

instrumenter”.

I pensionskassens investeringspolitik tages der hensyn til en række sociale, miljømæssige og etiske

forhold. Pensionskassen investerer ikke i virksomheder, der overlagt og konsekvent overtræder national

lovgivning eller regler fastsat af internationale organisationer tiltrådt af Danmark. Endvidere investerer

pensionskassen ikke i kontroversielle våben, kulminer eller tobak.

For afledte finansielle instrumenter knytter væsentlige betingelser sig til udviklingen i renter,

aktiekurser og valuta.

For øvrige finansielle instrumenter, såsom obligationer, kapitalandele mv., er der ingen specielle

væsentlige betingelser eller vilkår, som influerer på de fremtidige betalingsstrømme.

Page 67: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

31 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 10

Opdeling efter værdiansættelse af investeringsaktiver og finansielle forpligtelser

Ikke

Noterede Observerbare observerbare

kurser input input I alt

Investeringsejendomme 0,0 0,0 8,1 8,1

Kapitalandele i associerede virksomheder 0,0 0,0 284,1 284,1

Kapitalandele 5,9 0,0 228,8 234,7

Investeringsforeningsandele 2.423,4 2.023,1 1.010,4 5.456,9

Obligationer 2.801,4 2.994,3 0,0 5.795,7

Andre udlån 0,0 0,0 257,8 257,8

Indlån i kreditinstitutter 217,0 27,7 0,0 244,7

Afledte finansielle instrumenter 0,0 73,3 12,4 85,7

Investeringsaktiver til dagsværdi 5.447,6 5.118,5 1.801,7 12.367,8

Gæld vedrørende afledte finansielle instrumenter 0,0 -43,6 -31,4 -75,0

Gæld til kreditinstitutter 0,0 -1.334,5 0,0 -1.334,5

Finansielle forpligtelser til dagsværdi 0,0 -1.378,0 -31,4 -1.409,5

Værdiansættelse baseret på ikke observerbare input

Dagsværdi primo 1.526,9

Overførsler til/fra andre niveauer 0,0

Køb/Salg netto 220,2

Værdiregulering 23,2

Dagsværdi ultimo 1.770,3

Note 11 Pensionskassen Koncernen

Sikkerhedsstillelse 2019 2018 2019 2018

32,5 401,7 32,5 401,7

25,9 29,5 25,9 29,5

1.333,9 560,4 1.333,9 560,4

Likvider og obligationer modtaget til sikkerhed

for dagsværdien på afledte finansielle

instrumenter

Pensionskassen har til sikkerhed for clearing og

for dagsværdien på afledte finansielle

instrumenter netto deponeret obligationer til en

værdi af

Investeringsaktiver og finansielle forpligtelser er indregnet til dagsværdi eller amortiseret kostpris og

opgjort på koncernniveau jf. nærmere herom i note 1 "Anvendt regnskabspraksis"

Sikkerhedsstillelse for repo forretninger

Page 68: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

32 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 12Eventualaktiv

Note 13 Pensionskassen KoncernenOverskudskapital 2019 2018 2019 2018

Overskudskapital primo 406,6 422,5 406,6 422,5

Indbetalinger 10,6 10,4 10,6 10,4

Udbetalinger -19,1 -17,7 -19,1 -17,7

Andel af realiseret resultat efter

pensionsafkastskat 47,5 -8,7 47,5 -8,7 Overskudskapital i alt 445,6 406,6 445,6 406,6

Note 14 Pensionskassen Koncernen

Pensionshensættelser 2019 2018 2019 2018

Pensionshensættelser primo 8.546,5 8.955,3 8.546,5 8.955,3

Fortjenstmargen primo 0,0 0,0 0,0 0,0

Anvendt individuel bonuspotentiale 511,6 0,0 511,6 0,0

Pensionsmæssige hensættelser i alt primo 9.058,1 8.955,3 9.058,1 8.955,3

Kollektiv bonuspotentiale primo 0,0 0,0 0,0 0,0

Akkumuleret værdiregulering primo -212,9 -272,9 -212,9 -272,9

Retrospektive hensættelser primo 8.845,2 8.682,4 8.845,2 8.682,4

Bruttobidrag 202,4 199,5 202,4 199,5

Rentetilskrivning 349,0 342,7 349,0 342,7

Pensionsydelser -497,1 -463,3 -497,1 -463,3

-3,3 -3,9 -3,3 -3,9

39,3 7,3 39,3 7,3

55,1 51,3 55,1 51,3

8,5 7,3 8,5 7,3

4,2 2,4 4,2 2,4

9.003,3 8.845,2 9.003,3 8.845,2

270,0 212,9 270,0 212,9

Kollektiv bonuspotentiale ultimo 0,0 0,0 0,0 0,0

Pensionsmæssige hensættelser i alt ultimo 9.273,3 9.058,1 9.273,3 9.058,1

-35,1 -511,6 -35,1 -511,6

0,0 0,0 0,0 0,0

Pensionshensættelser i alt 9.238,1 8.546,5 9.238,1 8.546,5

Akkumuleret værdiregulering ultimo

Retrospektive hensættelser ultimo

Fortjenstmargen ultimo

Pensionskassens forsikringer er omfattet af kontributionsprincippet. Pensionskassen har imidlertid

vedtaget andre principper for fordeling af det realiserede resultat end, hvad der følger af

kontributionsbekendtgørelsen (BEK nr. 1643 af 14. december 2016). Bekendtgørelsens bestemmelser

følges i det omfang, de ikke strider imod pensionskassens principper. I praksis vil det sige, at

pensionskassen ikke anvender en gruppeopdeling efter bekendtgørelsens § 3.

I 2014 blev dansk momspraksis ændret, hvorefter der ikke skal betales moms for visse ydelser til

pensionskasser.

Risikogevinst efter tilskrivning af risikobonus

Egenkapitalfinansierede ydelser

Pensionskassen har indsendt anmodning om tilbagebetaling af uberettiget opkrævet moms til SKAT, og

anmodninger afventer sagsbehandling. Det er uklart i hvilket omfang Pensionskassen vil opnå

tilbagebetaling og dermed størrelsen af det forventede samlede tilgodehavende.

Omkostningstillæg efter tilskrivning af

omkostningsbonus

Andet

Anvendt individuel bonuspotentiale

Overført til/fra medlemskapital

Page 69: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

33 Årsrapport 2019

Pensionskassen for Farmakonomer

Individuelt Kollektivt

Garanterede bonus- bonus-

ydelser potentiale potentiale I alt

Pensionshensættelser pr. 1. januar 2019

Opgørelsesrente 0,0% 5.529,1 2.375,4 0,0 7.904,5

Opgørelsesrente 4,5% 547,4 0,6 0,0 548,0

Alle grupper 6.076,5 2.376,0 0,0 8.452,5

Risikomargen alle grupper 93,9

Pensionshensættelser i alt 8.546,5

Individuelt Kollektivt

Garanterede bonus- bonus-

ydelser potentiale potentiale I alt

Pensionshensættelser pr. 31. december 2019

Opgørelsesrente 0,0% 6.149,6 2.367,0 0,0 8.516,5

Opgørelsesrente 4,5% 586,7 0,6 0,0 587,3

Alle grupper 6.736,3 2.367,5 0,0 9.103,8

Risikomargen alle grupper 134,3

Pensionshensættelser i alt 9.238,1

2019 2018 2019 2018

Afkast-

procent

Afkast-

procent

Bonus-

grad

Bonus-

grad

Opgørelsesrente 0,0% 13,3% -2,4% 27,4% 28,0%

Opgørelsesrente 4,5% 13,3% -2,4% 0,2% 0,2%

2019 2018

Gennemsnitrente 13,9% -2,0%

Fordeling af hensættelser på oprindelig

grundlagsrente for bestande, der ikke er

omfattet af kontributionsprincippet:

Note 14 fortsat

Forrentning af kundemidler efter

omkostninger før skat opdelt på produkt:

Afkastprocent og Bonusgrad for de

forsikringsbestande, der ikke er omfattet

af kontributionspricippet:

Note 14 fortsat

Page 70: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

34 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 15 Pensionskassen Koncernen

Eventualforpligtelser 2019 2018 2019 2018

Investeringsejendomme og andre

materielle investeringsaktiver 3,6 3,6 3,6 3,6

Kapitalandele i tilknyttede virksomheder 0,5 0,5 0,5 0,5

Kapitalandele i associerede virksomheder 284,1 250,8 284,1 250,8

Kapitalandele 245,2 118,6 245,2 118,6

Investeringsforeningsandele 4.637,4 4.438,0 4.637,4 4.438,0

Obligationer 4.607,8 4.390,8 4.607,8 4.390,8

Andre udlån 115,0 77,3 115,0 77,3

Indlån i kreditinstitutter 231,3 94,2 231,3 94,2

Tilgodehavende renter 16,2 25,0 16,2 25,0

Til sikkerhed for hensættelser i alt 10.141,2 9.398,8 10.141,2 9.398,8

Investeringsaktiver til overtagelse efter

regnskabsåret 175,0 0,0 175,0 0,0

Unoterede aktier 371,3 129,7 371,3 129,7

Ejendomme 153,7 42,6 153,7 42,6

Infrastruktur 26,2 26,0 26,2 26,0

Kredit 420,0 104,0 420,0 104,0

971,2 302,3 971,2 302,3

North Sea Infrastructure

Blafa

Zion

El Campo

PKA overtog i oktober 2018 49% af to solcelleparker i Californien. Begge solparker var fuldt udbygget

og i drift på overtagelsestidspunktet. Pensionskassen har garanteret sin pro rata andel af visse drifts-

og nedtagningsmæssige forpligtelser overfor Nordea Bank. Garantiforpligtelsen beløber sig pr.

statusdagen til 0,6 mio. USD.

I oktober 2018 indgik Pensionskassen en aftale med Vattenfall og Vestas om opførelsen af en 353 MW

onshore vindmøllepark i Sverige nær Umeå. Pensionskassens garantiforpligtelse pr. statusdagen

udgøres af resterende pro rata andel af det samlede investeringstilsagn samt yderligere driftsmæssige

garantier på i alt 20,9 mio. DKK.

Til sikkerhed for forsikredes hensættelser er

registreret følgende aktiver:

Pensionskassen har sammen med Borgland Advisory AS investeret i Vestprosess gas- og

kondensatprocesseringsanlæg i oktober 2019. Aktivet er beliggende i det vestlige Norge nordvest for

Bergen. Som led i den samlede finansiering er der på statusdagen en forpligtelse på restkøbesummen

på 6,5 mio. NOK.

Tilsagn om investeringer fratrukket allerede

indbetalte beløb:

I 2019 indgik Pensionskassen en aftale med Longroad og Vestas om opførelsen af en 353 MW onshore

vindmøllepark i USA, Knox County, Texas. Pensionskassens garantiforpligtelse pr. statusdagen udgøres

af resterende pro rata andel af det samlede investeringstilsagn samt yderli-gere driftsmæssige

garantier på i alt 7,5 mio. USD.

Page 71: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

35 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 16

Nærtstående parter m.v.

Pensionskassen har

kapitalandele i følgende

tilknyttede virksomheder: Aktivitet Hjemsted

Ejer-

andel Resultat

Egen-

kapital

Farmakonomernes

Ejendomsaktieselskab

Investering i grunde og

bygningerGentofte 100,0% -0,2 10,5

Farmapension A/S Administration København 100,0% 0,0 0,5

Pensionskassen har

kapitalandele i følgende

associerede

virksomheder: Aktivitet Hjemsted

Ejer-

andel Resultat

Egen-

kapital

DEAS Invest I Holding A/S Ejendomsadministration Frederiksberg 33,3% 101,1 731,7

Der er ikke nogen nærtstående parter, som har bestemmende indflydelse i Pensionskassen.

Der har ikke været andre transaktioner med bestyrelsen og direktionen end vederlag jf. Note 6

Pensionskassernes Administration A/S varetager administrative opgaver for Pensionskassen. Der er

indgået administrationsaftale og ydelserne afregnes på markedsbaserede vilkår. De administrative

opgaver omfatter pensionsadministration, formueforvaltning.

Page 72: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the

36 Årsrapport 2019

Pensionskassen for Farmakonomer

Note 17

Risikooplysninger

Der knytter sig en række risici til pensionskassens forretningsmodel.

• Livsforsikringsrisici

• Markedsrisici, herunder renterisici

• Outsourcingrisiko

Pensionskassen anvender outsourcing, hvilket giver anledning til fokus på de risici, der følger med.

Risikoen er, at der opstår tab som følge af mangelfulde aftaler eller kontrol. Pensionskassen har indgået

outsourcingaftale med PKA A/S om fuldstændig administration. Bestyrelsen har fastlagt politik og

retningslinjer for outsourcing af væsentlige aktivitetsområder. Heri fastlægges reglerne for yderligere

outsourcing til tredjepart. Det sikrer en tilfredsstillende opfølgning på de respektive underleverandører

som f.eks. Forca A/S.

Bestyrelsen har i forbindelse med arbejdet med risiko og solvens identificeret de væsentligste risici, der

knytter sig til forretningsmodellen:

Inden for livsforsikringsrisici er de biometriske risici, der omfatter levetidsforbedringer og ændringer i

antallet af førtidspensionister, de væsentligste risici. Pensionskassen justerer løbende, med

udgangspunkt i Finanstilsynets levetidsregime, sine forudsætninger om forventet levetid hos

medlemmerne. Pensionskassens tilsagn er primært givet med betinget garanti, dvs. at pensionskassen

har muligheden for at nedsætte parametrene i det tekniske grundlag for at sikre pensionskassens

solvens ved uventet udvikling af forudsætningerne i grundlaget. I så fald nedsættes grundpensionerne.

Markedsrisici er defineret som risikoen for, at markedsværdien af aktiver og passiver ændres som følge

af ændringer i markedsforholdene. De væsentligste markedsrisici findes inden for renter, aktier, valuta

og reale aktiver samt ved investeringer i alternative afkastkilder. Pensionskassen styrer risiciene ved at

sikre den nødvendige spredning af investeringerne. Bestyrelsen har i investeringsstrategien fastsat

risikorammer for de forskellige aktivklasser.

Pensionskassen afdækker renterisiko på de garanterede ydelser ud fra bestyrelsens vedtagne ramme

for renterisiko. Konsekvensen ved renteafdækningen er, at en væsentlig del af renterisikoen mellem

passiver og aktiver er elimineret. En vigtig del af aktiverne til renteafdækning er renteswaps, hvor

pensionskassen betaler en variabel rente og modtager en fast rente. Disse instrumenter har samme

egenskab som de garanterede ydelser på den måde, at de stiger i værdi, hvis renten falder og

omvendt.

Note 18

Specifikation aktiver og disses afkast

Primo Ultimo

Grunde og bygninger 46,4 22,4 6,4

Noterede kapitalandele 1.942,9 1.806,6 26,6

Unoterede kapitalandele 499,0 644,1 11,2

Kapitalandele i alt 2.441,8 2.450,7 23,4

Stats- og realkreditobligationer 5.215,6 5.749,8 4,1

Indeksobligationer 0,0 0,0 0,0

Kreditobligationer og emerging markets obligationer 2.431,2 3.347,4 11,3

Udlån m.v. 131,4 287,8 4,6

Obligationer og udlån i alt 7.778,1 9.385,0 6,6

Dattervirksomheder 0,0 0,0 0,0

Øvrige investeringsaktiver 252,9 340,8 -9,2

Afledte finansielle instrumenter til sikring af

nettoændringen af aktiver og forpligtelser 48,8 98,9

Afkast i % er tidsvægtet på baggrund af afkastet på dagsbasis.

Regnskabsmæssig værdi Afkast i % p.a.

før skat

Page 73: The Pharmaconomists’ Pension Fund...the Pension Fund is not growing, since pension payments exceed members’ contributions. The total return before the pension return tax on the